US20180042675A1 - Methods and apparatus for multi-catheter tissue ablation - Google Patents
Methods and apparatus for multi-catheter tissue ablation Download PDFInfo
- Publication number
- US20180042675A1 US20180042675A1 US15/795,075 US201715795075A US2018042675A1 US 20180042675 A1 US20180042675 A1 US 20180042675A1 US 201715795075 A US201715795075 A US 201715795075A US 2018042675 A1 US2018042675 A1 US 2018042675A1
- Authority
- US
- United States
- Prior art keywords
- electrodes
- anode
- electrode
- catheter
- cathode
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
- A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
- A61B18/14—Probes or electrodes therefor
- A61B18/1492—Probes or electrodes therefor having a flexible, catheter-like structure, e.g. for heart ablation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
- A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
- A61B18/1206—Generators therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B2017/00017—Electrical control of surgical instruments
- A61B2017/00137—Details of operation mode
- A61B2017/00154—Details of operation mode pulsed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00315—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for treatment of particular body parts
- A61B2018/00345—Vascular system
- A61B2018/00351—Heart
- A61B2018/00363—Epicardium
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00571—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for achieving a particular surgical effect
- A61B2018/00577—Ablation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00571—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for achieving a particular surgical effect
- A61B2018/00613—Irreversible electroporation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00636—Sensing and controlling the application of energy
- A61B2018/00642—Sensing and controlling the application of energy with feedback, i.e. closed loop control
- A61B2018/00654—Sensing and controlling the application of energy with feedback, i.e. closed loop control with individual control of each of a plurality of energy emitting elements
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00636—Sensing and controlling the application of energy
- A61B2018/00666—Sensing and controlling the application of energy using a threshold value
- A61B2018/00672—Sensing and controlling the application of energy using a threshold value lower
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00636—Sensing and controlling the application of energy
- A61B2018/00696—Controlled or regulated parameters
- A61B2018/00702—Power or energy
- A61B2018/00708—Power or energy switching the power on or off
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00636—Sensing and controlling the application of energy
- A61B2018/00773—Sensed parameters
- A61B2018/00839—Bioelectrical parameters, e.g. ECG, EEG
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00636—Sensing and controlling the application of energy
- A61B2018/00773—Sensed parameters
- A61B2018/00875—Resistance or impedance
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
- A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
- A61B18/1206—Generators therefor
- A61B2018/124—Generators therefor switching the output to different electrodes, e.g. sequentially
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
- A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
- A61B18/1206—Generators therefor
- A61B2018/1246—Generators therefor characterised by the output polarity
- A61B2018/126—Generators therefor characterised by the output polarity bipolar
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
- A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
- A61B18/1206—Generators therefor
- A61B2018/1266—Generators therefor with DC current output
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/327—Applying electric currents by contact electrodes alternating or intermittent currents for enhancing the absorption properties of tissue, e.g. by electroporation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/362—Heart stimulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/362—Heart stimulators
- A61N1/365—Heart stimulators controlled by a physiological parameter, e.g. heart potential
- A61N1/368—Heart stimulators controlled by a physiological parameter, e.g. heart potential comprising more than one electrode co-operating with different heart regions
- A61N1/3688—Heart stimulators controlled by a physiological parameter, e.g. heart potential comprising more than one electrode co-operating with different heart regions configured for switching the pacing mode, e.g. from AAI to DDD
Definitions
- the embodiments described herein relate generally to medical devices for therapeutic electrical energy delivery, and more particularly to systems and methods for delivering electrical energy in the context of ablating tissue rapidly and selectively by the application of suitably timed pulsed voltages that generate irreversible electroporation of cell membranes.
- the applied electric field at the membrane exceeds a threshold value, typically dependent on cell size, the electroporation is irreversible and the pores remain open, permitting exchange of material across the membrane and leading to apoptosis or cell death. Subsequently, the surrounding tissue heals in a natural process.
- some known catheters and systems include a single multi-electrode catheter in which certain electrodes receive a voltage signal having a first polarity and other electrodes receive a voltage signal having the opposite polarity. Accordingly, to minimize the risk of dielectric breakdown within the catheter, such known catheters typically include substantial insulation (e.g., around the leads), thus increasing the size and limiting the flexibility of the catheter.
- Some known catheters configured to produce voltage pulses of up to 5 kV include catheter leads having an insulation of as much as 0.2 mm and an overall size of about 14 French (4.67 mm).
- an apparatus includes a voltage pulse generator and an electrode controller.
- the voltage pulse generator is configured to produce a pulsed voltage waveform.
- the electrode controller is configured to be operably coupled to the voltage pulse generator.
- the electrode controller includes a first output port and a second output port.
- the first output port is configured to be operatively coupled to a first medical device including a first set of electrodes
- the second output port is configured to be operatively coupled to a second medical device including a second set of electrodes.
- the electrode controller includes a selection module and a pulse delivery module.
- the selection module is configured to select at least a first electrode from the first set of electrodes and identify at least the first electrode as an anode.
- the selection module is configured to select at least a second electrode from the second set of electrodes and identify at least the second electrode as a cathode.
- the pulse delivery module is configured to deliver a first output signal having a first polarity and being associated with the pulsed voltage waveform to the first output port for application to the first electrode.
- the pulse delivery module is configured to deliver a second output signal having a second polarity opposite the first polarity and being associated with the pulsed voltage waveform to the second output port for application to the second electrode.
- FIG. 1 is a perspective view showing two catheters according to an embodiment, each with multiple electrodes disposed along its shaft and wrapped around a portion of the pulmonary veins and being within the epicardial space of the heart in a subject body such that they form an approximately closed contour around the pulmonary veins.
- FIG. 2 is a schematic illustration of a catheter according to an embodiment, with a multiplicity of electrodes disposed along its shaft, with an electrical lead attached to the inner side of each electrode, and with a magnet located near the distal end of the catheter.
- FIG. 3 illustrates two flexible catheter devices with multiple electrodes disposed along their shafts and positioned to wrap around respective approximate halves of a single closed contour around the pulmonary veins in the epicardial space of the heart, with their distal ends positioned in close proximity.
- FIG. 4 is an illustration of two flexible catheter devices with multiple electrodes disposed along their shafts and positioned to wrap around respective approximate halves of a single closed contour around the pulmonary veins in the epicardial space of the heart, with active electrodes identified according to an embodiment.
- FIG. 5A is a schematic illustration of an irreversible electroporation system according to an embodiment that includes a voltage/signal generator, a controller capable of being configured to apply voltages to selected subsets of electrodes with independent subset selections for anode electrodes on one medical device and cathode electrodes on a second medical device.
- FIG. 5B is a schematic illustration of an irreversible electroporation system according to an embodiment that includes a voltage/signal generator, a controller capable of being configured to apply voltages to selected subsets of electrodes with independent subset selections for anode electrodes on one medical device and cathode electrodes on a second medical device.
- FIG. 6 is an illustration of an ECG waveform showing the refractory periods during atrial and ventricular pacing, and the time windows for irreversible electroporation ablation.
- FIG. 7 is a schematic illustration of a method of selecting subsets of electrodes on two catheters as anodes or cathodes, according to an embodiment, whereby the ablation vector or predominant current density direction vector is selected for ablation.
- FIG. 8 is a schematic illustration of a user interface of the present invention, showing electrodes on two catheters, and buttons for selection or marking of anode electrode subsets and cathode electrode subsets.
- FIG. 9 is a schematic illustration of a user interface according to an embodiment, for selection of anode and cathode electrode subsets, showing a single selected anode electrode on one catheter and two selected cathode electrodes on a second catheter.
- FIG. 10 is a schematic illustration of a waveform generated by the irreversible electroporation system according to an embodiment, showing a balanced square wave.
- FIG. 11 is a schematic illustration of a waveform generated by the irreversible electroporation system according to an embodiment, showing a balanced biphasic square wave.
- FIG. 12 is a schematic illustration of a waveform generated by the irreversible electroporation system according to an embodiment, showing a progressive balanced biphasic square wave.
- an irreversible electroporation system includes a DC voltage/signal generator and a controller capable of being configured to apply voltages to a selected multiplicity or a subset of electrodes, with anode and cathode subsets being selected independently on distinct medical devices.
- the controller is additionally capable of applying control inputs whereby selected pairs of anode-cathode subsets of electrodes can be sequentially updated based on a pre-determined sequence.
- an irreversible electroporation system includes a DC voltage/signal generator and a controller capable of being configured to apply voltages to a selected multiplicity or a subset of electrodes, with independent subset selections for anode and cathode electrode selections on distinct catheter devices respectively. Further, the controller is capable of applying control inputs whereby selected pairs of anode-cathode subsets of electrodes can be sequentially updated based on a pre-determined sequence.
- the generator can output waveforms that can be selected to generate a sequence of voltage pulses in either monophasic or biphasic forms and with either constant or progressively changing amplitudes.
- an apparatus in some embodiments, includes a voltage pulse generator and an electrode controller.
- the voltage pulse generator is configured to produce a pulsed voltage waveform.
- the electrode controller is configured to be operably coupled to the voltage pulse generator.
- the electrode controller includes a first output port and a second output port.
- the first output port is configured to be operatively coupled to a first medical device including a first set of electrodes
- the second output port is configured to be operatively coupled to a second medical device including a second set of electrodes.
- the electrode controller includes a selection module and a pulse delivery module.
- the selection module is configured to select at least a first electrode from the first set of electrodes and identify at least the first electrode as an anode.
- the selection module is configured to select at least a second electrode from the second set of electrodes and identify at least the second electrode as a cathode.
- the pulse delivery module is configured to deliver a first output signal having a first polarity and being associated with the pulsed voltage waveform to the first output port for application to the first electrode.
- the pulse delivery module is configured to deliver a second output signal having a second polarity opposite the first polarity and being associated with the pulsed voltage waveform to the second output port for application to the second electrode.
- an apparatus in some embodiments, includes a voltage pulse generator and an electrode controller.
- the voltage pulse generator is configured to produce a pulsed voltage waveform.
- the electrode controller is configured to be operably coupled to the voltage pulse generator.
- the electrode controller includes a first output port and a second output port, the first output port configured to be operatively coupled to a first medical device including a first set of electrodes, the second output port configured to be operatively coupled to a second medical device including a second set of electrodes.
- the electrode controller includes a selection module and a pulse delivery module.
- the selection module is configured to select a set of anode/cathode pairs, each anode selected being only in the first plurality of electrodes, each cathode selected being only in the second plurality of electrodes.
- the pulse delivery module is configured to deliver a first output signal having a first polarity and associated with the pulsed voltage waveform to the first output port for application to each anode selected.
- the pulse delivery module is configured to deliver a second output signal having a second polarity opposite the first polarity and associated with the pulsed voltage waveform to the second output port for application to each cathode selected.
- the pulse delivery module is configured to deliver the first output signal and the second output signal to the plurality of anode/cathode pairs according to a sequential pattern.
- a method includes identifying, via a selection module of an electrode controller, a set of anode/cathode pairs, each anode selected being only in a first set of electrodes of a first multi-electrode catheter, each cathode selected being only in a second set of electrodes of a second multi-electrode catheter.
- the first multi-electrode catheter and the second multi-electrode catheter are configured to collectively surround a portion of a heart.
- a pacing signal is conveyed to a pacing lead configured to be operatively coupled to the heart.
- the method includes receiving, at a feedback module, an electrocardiograph signal associated with a function of the heart.
- the method includes delivering, via a pulse delivery module of the electrode controller, a first output signal having a first polarity to each anode selected, and delivering, via the pulse delivery module, a second output signal having a second polarity opposite the first polarity to each cathode selected.
- the first output signal and the second output signal are delivered according to a sequential pattern.
- a non-transitory processor readable medium storing code representing instructions to be executed by a processor includes code to cause the processor to identify a set of anode/cathode pairs. Each anode in the plurality of anode/cathode pairs being only in a first set of electrodes of a first multi-electrode catheter. Each cathode in the set of anode/cathode pairs being only in a second set of electrodes of a second multi-electrode catheter.
- the first multi-electrode catheter and the second multi-electrode catheter are configured to collectively surround a portion of a heart.
- the code further includes code to convey a pacing signal to a pacing lead configured to be operatively coupled to the heart, and receive an electrocardiograph signal associated with a function of the heart.
- the code further includes code to deliver, according to a sequential pattern, a first output signal having a first polarity to each anode selected and a second output signal having a second polarity opposite the first polarity to each cathode selected.
- system includes a first flexible catheter including a first set of electrodes and a second flexible catheter including a second set of electrodes.
- a distal end portion of the first flexible catheter is configured to be coupled to a distal end portion of the second catheter to form a continuous length including the first set of electrodes and the second set of electrodes.
- the first flexible catheter and the second flexible catheter are configured to deliver a bipolar voltage signal to a target tissue such that a first portion of the bipolar voltage signal having a first polarity is delivered only to the first set of electrodes and a second portion of the bipolar voltage signal having second polarity opposite the first polarity is delivered only to the second set of electrodes.
- a member is intended to mean a single member or a combination of members
- a material is intended to mean one or more materials
- a processor is intended to mean a single processor or multiple processors
- memory is intended to mean one or more memories, or a combination thereof.
- the terms “about” and “approximately” generally mean plus or minus 10% of the value stated. For example, about 0.5 would include 0.45 and 0.55, about 10 would include 9 to 11, about 1000 would include 900 to 1100.
- a Pulmonary Vein isolation (PV isolation) system includes two ablation catheter devices, one (labeled 5 ) with distal end 15 and proximal portion 8 , the other (labeled 6 ) with distal end 16 and proximal portion 9 , each with a multiplicity of electrodes (indicated by dark bands such as those marked as 19 ) disposed along its length, and where each catheter is wrapped in the epicardial space around a portion of the pulmonary veins 10 , 11 , 12 and 13 of a heart 7 in a subject or patient anatomy, with the proximal portions 8 and 9 of the respective catheters 5 and 6 extending out and away to eventually emerge from the patient's chest.
- V isolation Pulmonary Vein isolation
- the distal ends of the two catheters 5 and 6 have magnets 15 and 16 respectively that can aid in alignment of the two catheters.
- the ablation catheters 5 and 6 , and any of the catheters described herein can be similar to the ablation catheters described in PCT Publication No. WO2014/025394, entitled “Catheters, Catheter Systems, and Methods for Puncturing Through a Tissue Structure,” filed on Mar. 14, 2013 (“the '394 PCT Application), which is incorporated herein by reference in its entirety.
- the ablation catheters 5 and 6 can be disposed about the pulmonary veins 10 , 11 , 12 and 13 using any suitable procedure and apparatus.
- the ablation catheters can be disposed about the pulmonary veins 10 , 11 , 12 and 13 and/or the heart 7 using a puncturing apparatus disposed via a subxiphoid pericardial access location and a using guidewire-based delivery method as described in the '394 PCT Application. Similar methods can be used to deliver and position the two catheters 5 and 6 . After the ends 8 and 9 of the two respective catheters 5 and 6 extend and emerge out of the patient chest they can be cinched together to effectively hold the catheters in place or in stable positions relative to each other.
- a DC voltage for electroporation can be applied to subsets of electrodes identified as anodes and cathodes respectively on the two catheters on approximately opposite sides of the closed contour defined by the shapes of the catheters 5 and 6 around the pulmonary veins.
- the DC voltage is applied in brief pulses sufficient to cause irreversible electroporation and can be in the range of 0.5 kV to 10 kV and more preferably in the range 1 kV to 2.5 kV, so that a threshold electric field value of around 200 Volts/cm is effectively achieved in the cardiac tissue to be ablated.
- the marked or active electrodes on the two catheters can be automatically identified, or manually identified by suitable marking, on an X-ray or fluoroscopic image obtained at an appropriate angulation that permits identification of the geometric distance between anode and cathode electrodes, or their respective centroids.
- the DC voltage generator setting for irreversible electroporation is then automatically identified by the electroporation system based on this distance measure.
- the DC voltage value is selected directly by a user from a suitable dial, slider, touch screen, or any other user interface.
- the DC voltage pulse results in a current flowing between the anode and cathode electrodes on opposite sides of the contour defined by the conjoint shapes of the two catheters, with said current flowing through the cardiac wall tissue and through the intervening blood in the cardiac chamber, with the current entering the cardiac tissue from the anode electrodes and returning back through the cathode electrodes.
- the forward and return current paths are respectively inside distinct catheters, since all active electrodes on a given catheter are of like polarity. Areas of cardiac wall tissue where the electric field is sufficiently large for irreversible electroporation are ablated during the DC voltage pulse application.
- FIG. 2 is a schematic illustration of a multi-electrode, magnet-tipped catheter according to an embodiment.
- the catheter shaft 801 has a multiplicity of electrodes disposed along an extensive length of catheter at least 5 cm in extent.
- the metallic electrodes could be poly-metallic in construction, for example, including regions of Titanium and regions of Platinum.
- FIG. 2 shows only four electrodes 803 , 804 , 805 and 806 for clarity, in other embodiments, the number of electrodes can be in the range between 5 and 30, and more preferably in the range between 8 and 18.
- Each electrode attaches to a corresponding lead, thus as shown in FIG. 2 , electrodes 803 , 804 , 805 and 806 attach to leads 813 , 814 , 815 and 816 , respectively.
- the catheter shaft is made of a flexible polymeric material such as for example Teflon, Nylon or Pebax.
- the leads 813 , 814 , 815 and 816 include an insulative covering to ensure that each lead/electrode is electrically isolated from the other leads and electrodes coupled to the catheter shaft 801 .
- all of the electrodes 803 , 804 , 805 and 806 of the catheter 801 have the same polarity.
- the need for high dielectric strength material separating the leads is not a significant constraint. Accordingly, the insulative material covering each lead can be minimized, and the catheter can be relatively small in diameter.
- the catheter device can have a high degree of flexibility to facilitate the method of surrounding the pulmonary veins as described herein.
- the catheter device can have a size in the range of approximately 9 French (3 mm), 8 French (2.67 mm) or even 6 French (2 mm).
- the electrode leads of the catheter device can have an insulation thickness of less than about 0.05 mm, less than about 0.01 m, or less than about 0.005 mm. In other embodiments, the electrode leads of the catheter can have an insulation thickness of between about 0.03 mm and about 0.06 mm.
- the catheter device 801 can enhance the efficacy of irreversible electroporation ablation.
- the voltage applied to the electrodes 803 , 804 , 805 and 806 can be in the range of 0.5 kV to 2.5 kV; 2.5 kV to 5 kV, and up to 10 kV and more preferably in the range 1 kV to 2.5 kV.
- the distal end of the catheter 801 has a ring-shaped magnet 809 , with the magnet having a magnetization direction that is substantially aligned with the longitudinal axis of the catheter.
- the magnet 809 is configured to have a polarity to cooperate with a corresponding magnet from a second catheter to be used in conjunction with the catheter 801 .
- the magnets 15 and 16 shown respectively at the distal ends of the two catheters 5 and 6 in FIG. 1 have opposite polarities on their distal faces, so that they attract each other. This attraction can aid in approximate alignment and/or coupling of the catheters.
- anode and cathode electrodes for voltage application can be selected on distinct devices in accordance with the methods described herein.
- each of the catheters includes fewer electrodes and few leads than if a single catheter were used to surround the heart.
- the reduction of the number of leads and electrodes also allows for an overall reduction in the size of the catheter, improvement in the flexibility thereof, and the like.
- a system in some embodiments, for example, includes a first catheter including a first set of electrodes and a second flexible catheter including a second set of electrodes.
- Each of the catheters can be, for example, the catheter 801 .
- a distal end portion of the first flexible catheter is configured to be coupled to a distal end portion of the second catheter to form a continuous length including the first set of electrodes and the second set of electrodes.
- the connection can be via a magnetic coupling device, as shown herein.
- the first flexible catheter and the second flexible catheter are configured to deliver a bipolar voltage signal to a target tissue such that a first portion of the bipolar voltage signal having a first polarity is delivered only to the first set of electrodes and a second portion of the bipolar voltage signal having second polarity opposite the first polarity is delivered only to the second set of electrodes.
- FIG. 3 shows another example of the placement of a first catheter 538 and a second catheter 539 , according to an embodiment.
- the first catheter 538 and the second catheter 539 can each be constructed of a small diameter tube covered by multiple metal electrodes.
- the distal ends of the catheters ( 544 and 554 respectively) contain magnets that attract and allow for alignment of the devices when their distal ends are in close proximity as indicated by region 545 .
- Electrodes 543 disposed along the first catheter 538 are of a single polarity (for instance, an activated subset of the electrodes would all be anodes), while electrodes 553 disposed along the second catheter 539 are all of the opposite polarity (in the same example, an activated subset could all be cathodes).
- Wires are connected to each electrode in the anode and cathode catheters, indicated by collective anode leads 542 and collective cathode leads 552 respectively.
- wires of opposite polarity are not in the same catheter, thereby reducing the possibility of dielectric breakdown at high voltage, as discussed above.
- Reduced diameter catheters can be significantly more flexible and a smaller number of leads in a given catheter (resulting in a smaller catheter diameter) can be advantageous in this regard. While in this example the two catheters are navigated and coupled magnetically, those skilled in the art could implement other means of alignment and positioning of the catheters without departing from the scope of the teachings herein.
- FIG. 4 shows the first catheter 538 and the second catheter 539 having proximal leads 542 and 552 , respectively, and having distal ends 544 and 554 , respectively.
- the a single active anode electrode 604 is selected on the second catheter 539
- two active cathode electrodes 601 and 602 are selected on the first catheter 538 .
- a DC voltage for irreversible electroporation ablation can then be applied across the selected anode-cathode electrodes.
- FIG. 5A A schematic diagram of an electroporation system according to an embodiment is shown in FIG. 5A .
- the system includes a DC voltage/signal generator 23 that is driven by a controller unit 21 .
- the controller unit 21 interfaces with a computer device 24 by means of a two-way communication link 29 .
- the controller interface can act as a multiplexer unit and perform channel selection and routing functions for applying DC voltages to appropriate electrodes that have been selected by a user or by the computer 24 .
- the controller can apply the voltages via a multiplicity of leads to a first catheter device 22 , as well as a second catheter device 122 .
- Active electrodes can be selected on a first catheter device 22 with one polarity, and likewise active electrodes can be selected on a second catheter device 122 with the opposite polarity.
- one or more leads from the controller 21 could also carry pacing signals to drive pacing of the heart through a separate pacing device (not shown).
- the catheter devices can also send back information such as ECG recordings or data from other sensors back to the controller 21 , possibly on separate leads.
- the DC voltage generator 23 sends a DC voltage to the controller 21 through leads 27 , the voltage generator is driven by control and timing inputs 28 from the controller unit 21 .
- the resulting ECG waveform 32 has appropriate respective refractory time intervals 33 and 34 respectively, during which there are suitable time windows for application of irreversible electroporation as indicated by 35 and 36 .
- the application of cardiac pacing results in a periodic, well-controlled sequence of electroporation time windows. Typically, this time window is of the order of hundreds of microseconds to about a millisecond or more. During this window, multiple DC voltage pulses can be applied to ensure that sufficient tissue ablation has occurred. The user can repeat the delivery of irreversible electroporation over several successive cardiac cycles for further confidence.
- a feedback module e.g., feedback module 905
- a pulse delivery module e.g., pulse delivery module 908
- a feedback module can receive the electrocardiograph signal
- a pulse delivery module e.g., pulse delivery module 908
- a pulse delivery module can deliver the output signal to the subset of electrodes during a time window associated with at least one a pacing signal or the electrocardiograph signal.
- the ablation controller and signal generator can be mounted on a rolling trolley, and the user can control the device using a touchscreen interface that is in the sterile field.
- the touchscreen can be for example an LCD touchscreen in a plastic housing mountable to a standard medical rail or post and can be used to select the electrodes for ablation and to ready the device to fire.
- the interface can for example be covered with a clear sterile plastic drape.
- the operator can select the number of electrodes involved in an automated sequence.
- the touch screen graphically shows the catheters that are attached to the controller. In one embodiment the operator can select electrodes from the touchscreen with appropriate graphical buttons.
- the operator can also select the pacing stimulus protocol (either internally generated or externally triggered) from the interface.
- the operator can initiate or verify pacing. Once the operator verifies that the heart is being paced, the ablation sequence can be initiated by holding down a hand-held trigger button that is in the sterile field.
- the hand-held trigger button can be illuminated red to indicate that the device is “armed” and ready to ablate.
- the trigger button can be compatible for use in a sterile field and when attached to the controller can be illuminated a different color, for example white.
- the trigger button flashes in sequence with the pulse delivery in a specific color such as red.
- the waveform of each delivered pulse is displayed on the touchscreen interface.
- a graphic representation of the pre and post impedance between electrodes involved in the sequence can also be shown on the interface, and this data can be exported for file storage.
- an impedance map can be generated based on voltage and current recordings across anode-cathode pairs or sets of electrodes (anodes and cathodes respectively being on distinct catheters), and an appropriate set of electrodes that are best suited for ablation delivery in a given region can be selected based on the impedance map or measurements, either manually by a user or automatically by the system.
- Such an impedance map can be produced, for example, by the feedback module 905 , or any other suitable portion of the electrode controller 900 .
- an electrode controller can automatically determine a subset of electrodes to which voltage pulses should be applied.
- the waveforms for the various electrodes can be displayed and recorded on the case monitor and simultaneously outputted to a standard connection for any electrophysiology (EP) data acquisition system.
- EP electrophysiology
- the waveforms acquired internally can be used to autonomously calculate impedances between each electrode pair.
- the waveform amplitude, period, duty cycle, and delay can all be modified, for example via a suitable Ethernet connection.
- Pacing for the heart is controlled by the device and outputted to the pacing leads and a protected pacing circuit output for monitoring by a lab.
- FIG. 7 shows a schematic rendering of a portion of the user interface of the electroporation system.
- the graphic shown in the FIG. represents a specific choice of electrode subsets for anode and cathode selection.
- the two PV isolation ablation catheters in the FIG. are represented by strings of numbered electrodes as indicated respectively by 591 and 592 , wrapped around the area 590 of the pulmonary veins represented by the gray region in this schematic diagram for ease of user visualization.
- the catheters 591 and 592 have proximal leads 651 and 652 respectively that connect to a controller or interface unit as described earlier.
- the arrows 595 and 596 represent approximate current density vectors, with one end at the cathodes and the other end at the anodes; in this figure, the three electrodes marked 601 and 602 are cathodes, and the single electrode marked 604 is the anode. It is apparent from FIG. 7 that the user can select various subsets of electrodes (respectively on distinct catheters) as cathode or anode, depending on the region to be ablated along the length of the contour around the pulmonary veins represented by the two catheters.
- the user can make one selection of cathode and anode subsets, and the system can take this selection as input to generate an ablation sequence that moves around the ring or contour defined by the shapes of the two PV isolation catheters, for example moving clockwise at each step with a one-electrode displacement.
- the pair of cathode and anode electrode subsets can be sequentially updated for ablation purposes, so that if there are N/2 electrodes on each catheter, after N updates the entire contour has been updated such that the current arrows shown as 595 and 596 have swept once around the contour completely.
- the portion of one of the PV isolation catheters with electrodes may be longer than needed to wrap around a given patient's pulmonary veins; in this event, a smaller number of electrodes is sufficient to wrap around the contour of the pulmonary veins. These define the number of “active” electrodes to be used in the ablation process.
- the system (any of the generators and controllers described herein) can deliver rectangular-wave pulses with a peak maximum voltage of about 5 kV into a load with an impedance in the range of 30 Ohm to 3000 Ohm for a maximum duration of 200 ⁇ s, with a 100 ⁇ s maximum duration being still more preferred.
- Pulses can be delivered in a multiplexed and synchronized manner to a multi-electrode catheter inside the body with a duty cycle of up to 50% (for short bursts).
- the pulses can generally be delivered in bursts, such as for example a sequence of between 2 and 10 pulses interrupted by pauses of between 1 ms and 1000 ms.
- the multiplexer controller is capable of running an automated sequence to deliver the impulses/impulse trains (from the DC voltage signal/impulse generator) to the tissue target within the body.
- the controller system is capable of switching between subsets/nodes of electrodes located on the single-use catheters. Further, the controller can measure voltage and current and tabulate impedances in each electrode configuration (for display, planning, and internal diagnostic analysis). It can also generate two channels of cardiac pacing stimulus output, and is capable of synchronizing impulse delivery with the internally generated cardiac pacing and/or an external trigger signal. In one embodiment, it can provide sensing output/connection for access to bio potentials emanating from each electrode connected to the system (with connectivity characteristics being compatible with standard electrophysiological laboratory data acquisition equipment).
- the controller e.g., the electrode controller 900
- the controller can automatically “recognize” each of the two single-use disposable catheters when it is connected to the controller output (prompting internal diagnostics and user interface configuration options).
- the controller can have at least two unique output connector ports (e.g., the first output port 940 and the second output port 942 ) to accommodate up to at least two catheters at once.
- the controller device can function as long as at least two recognized catheters are attached to it.
- the controller can have several sequence configurations that provide the operator with at least some variety of programming options.
- the controller can switch electrode configurations of a bipolar set of electrodes (cathodes and anodes respectively on distinct catheters) sequentially in a clockwise manner (for example, starting at a given step, in the next step of the algorithm, the next cathode electrode on one catheter and the next anode electrode on the other catheter are automatically selected, timed to the synchronizing trigger), with the two catheters and their electrodes arranged in a quasi-circumference around the target.
- pulse delivery occurs so that the approximate vector of current density changes as the automated sequencing of the controller switches “on” and “off” between different electrodes surrounding the tissue target sequence.
- the current density vectors generally cross the target tissue but in some configurations the current density could be approximately tangential to the target.
- the impulses are delivered to user-selected electrode subsets of catheters that are connected to the device (the vector of current density does not change with each synchronized delivery).
- the user can also configure the controller to deliver up to 2 channels of pacing stimulus to electrodes connected to the device output.
- the user can control the application of DC voltage with a single handheld switch.
- a sterile catheter or catheters can be connected to the voltage output of the generator via a connector cable that can be delivered to the sterile field.
- the user activates the device with a touch screen interface (that can be protected with a single-use sterile transparent disposable cover commonly available in the catheter lab setting).
- the generator can remain in a standby mode until the user is ready to apply pulses at which point the user/assistant can put the generator into a ready mode via the touchscreen interface. Subsequently the user can select the sequence, the active electrodes, and the cardiac pacing parameters.
- the user can initiate electrically pacing the heart (using a pacing stimulus generated by the ablation controller or an external source synchronized to the ablation system).
- the operator verifies that the heart is being paced and uses the hand-held trigger button to apply the synchronized bursts of high voltage pulses.
- the system can continue delivering the burst pulse train with each cardiac cycle as long as the operator is holding down a suitable “fire” button or switch.
- the generator output is synchronized with the heart rhythm so that short bursts are delivered at a pre-specified interval from the paced stimulus.
- the train of pulses is complete, the pacing continues until the operator discontinues pacing.
- FIG. 8 shows a portion of a user interface of the electroporation system for selection (with graphical button 701 ) of anode and cathode electrodes, with two catheters connected to the system.
- One of the catheters is a PV isolation catheter 591 while the other is a PV isolation catheter 592 , with their leads schematically indicated by 651 and 652 respectively.
- the buttons 703 and 704 can enable the selection of marked electrode subsets on the catheters as respectively anode or cathode with a “Continue” button 706 .
- the appropriate electrodes are colored differently to indicate anode or cathode electrodes as shown marked respectively as 719 and 721 on catheters 592 and 591 respectively in FIG. 9 .
- the controller and generator can output waveforms that can be selected to generate a sequence of voltage pulses in either monophasic or biphasic forms and with either constant or progressively changing amplitudes.
- FIG. 10 shows a rectangular wave pulse train where the pulses 101 have a uniform height or maximum voltage.
- FIG. 11 shows an example of a balanced biphasic rectangular pulse train, where each positive voltage pulse such as 103 is immediately followed by a negative voltage pulse such as 104 of equal amplitude and opposite sign. While in this example the biphasic pulses are balanced with equal amplitudes of the positive and negative voltages, in other embodiments an unbalanced biphasic waveform could also be used as may be convenient for a given application.
- FIG. 12 shows a progressive balanced rectangular pulse train, where each distinct biphasic pulse has balanced or equal-amplitude positive and negative voltages, but each pulse such as 107 is larger in amplitude than its immediate predecessor 106 .
- FIG. 12 shows a progressive balanced rectangular pulse train, where each distinct biphasic pulse has balanced or equal-amplitude positive and negative voltages, but each pulse such as 107 is larger in amplitude than its immediate predecessor 106 .
- Other variations such as a progressive unbalanced rectangular pulse train, or indeed a wide variety of other variations of pulse amplitude with respect to time can be conceived and implemented by those skilled in the art based on the teachings herein.
- the time duration of each irreversible electroporation rectangular voltage pulse could lie in the range from 1 nanosecond to 10 milliseconds, with the range 10 microseconds to 1 millisecond being more preferable and the range 50 microseconds to 300 microseconds being still more preferable.
- the time interval between successive pulses of a pulse train could be in the range of 10 microseconds to 1 millisecond, with the range 50 microseconds to 300 microseconds being more preferable.
- the number of pulses applied in a single pulse train (with delays between individual pulses lying in the ranges just mentioned) can range from 1 to 100, with the range 1 to 10 being more preferable.
- a pulse train can be driven by a user-controlled switch or button, in one embodiment preferably mounted on a hand-held joystick-like device.
- a pulse train can be generated for every push of such a control button, while in an alternate mode of operation pulse trains can be generated repeatedly during the refractory periods of a set of successive cardiac cycles, for as long as the user-controlled switch or button is engaged by the user.
- a method includes identifying, via a selection module of an electrode controller, a set of anode/cathode pairs. Each anode selected in the set of anode/cathode pairs is only in a first set of electrodes of a first multi-electrode catheter. Each cathode selected in the plurality of anode/cathode pairs is only in a second set of electrodes of a second multi-electrode catheter.
- the first multi-electrode catheter and the second multi-electrode catheter are configured to collectively surround a portion of a heart, as described herein.
- the identifying can be based on a predetermined schedule of electrodes. In yet other embodiments, the identifying can be performed automatically based on an impedance measurement or map as described herein.
- the method further includes conveying a pacing signal to a pacing lead configured to be operatively coupled to the heart, and receiving, at a feedback module of the electrode controller, an electrocardiograph signal associated with a function of the heart.
- the method further includes delivering, via a pulse delivery module of the electrode controller, a first output signal having a first polarity to each anode selected.
- the method further includes delivering, via the pulse delivery module, a second output signal having a second polarity to each cathode selected. The first output signal and the second output signal being delivered according to a sequential pattern.
- Some embodiments described herein relate to a computer storage product with a non-transitory computer-readable medium (also can be referred to as a non-transitory processor-readable medium) having instructions or computer code thereon for performing various computer-implemented operations.
- the computer-readable medium or processor-readable medium
- the media and computer code may be those designed and constructed for the specific purpose or purposes.
- non-transitory computer-readable media include, but are not limited to: magnetic storage media such as hard disks, floppy disks, and magnetic tape; optical storage media such as Compact Disc/Digital Video Discs (CD/DVDs), Compact Disc-Read Only Memories (CD-ROMs), and holographic devices; magneto-optical storage media such as optical disks; carrier wave signal processing modules; and hardware devices that are specially configured to store and execute program code, such as Application-Specific Integrated Circuits (ASICs), Programmable Logic Devices (PLDs), Read-Only Memory (ROM) and Random-Access Memory (RAM) devices.
- ASICs Application-Specific Integrated Circuits
- PLDs Programmable Logic Devices
- ROM Read-Only Memory
- RAM Random-Access Memory
- Examples of computer code include, but are not limited to, micro-code or micro-instructions, machine instructions, such as produced by a compiler, code used to produce a web service, and files containing higher-level instructions that are executed by a computer using an interpreter.
- embodiments may be implemented using imperative programming languages (e.g., C, Fortran, etc.), functional programming languages (Haskell, Erlang, etc.), logical programming languages (e.g., Prolog), object-oriented programming languages (e.g., Java, C++, etc.) or other suitable programming languages and/or development tools.
- Additional examples of computer code include, but are not limited to, control signals, encrypted code, and compressed code.
- controller 900 is shown as optionally including the pacing module 902 , in other embodiments, the controller 900 can interface with a separate pacing module.
- the controller 900 is shown as optionally including the feedback module 905 , in other embodiments, the controller 900 can interface with a separate feedback module.
- methods and/or events described above indicate certain events and/or procedures occurring in certain order, the ordering of certain events and/or procedures may be modified.
Landscapes
- Health & Medical Sciences (AREA)
- Surgery (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Heart & Thoracic Surgery (AREA)
- Medical Informatics (AREA)
- Otolaryngology (AREA)
- Plasma & Fusion (AREA)
- Physics & Mathematics (AREA)
- Biomedical Technology (AREA)
- Cardiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Molecular Biology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)
- Electrotherapy Devices (AREA)
- Surgical Instruments (AREA)
Abstract
Description
- This application is a continuation of PCT Application No. PCT/US2015/031086 titled “METHODS AND APPARATUS FOR MULTI-CATHETER TISSUE ABLATION”, filed May 15, 2015, which claims priority to U.S. Provisional Application Ser. No. 61/996,855, entitled “Method and Apparatus for Rapid Multi-Catheter Tissue Ablation,” filed May 16, 2014, the entire disclosures of which are incorporated herein by reference.
- The embodiments described herein relate generally to medical devices for therapeutic electrical energy delivery, and more particularly to systems and methods for delivering electrical energy in the context of ablating tissue rapidly and selectively by the application of suitably timed pulsed voltages that generate irreversible electroporation of cell membranes.
- The past two decades have seen advances in the technique of electroporation as it has progressed from the laboratory to clinical applications. Known methods include applying brief, high voltage DC pulses to tissue, thereby generating locally high electric fields, typically in the range of hundreds of Volts/centimeter. The electric fields disrupt cell membranes by generating pores in the cell membrane, which subsequently destroys the cell membrane and the cell. While the precise mechanism of this electrically-driven pore generation (or electroporation) awaits a detailed understanding, it is thought that the application of relatively large electric fields generates instabilities in the phospholipid bilayers in cell membranes, as well as mitochondria, causing the occurrence of a distribution of local gaps or pores in the membrane. If the applied electric field at the membrane exceeds a threshold value, typically dependent on cell size, the electroporation is irreversible and the pores remain open, permitting exchange of material across the membrane and leading to apoptosis or cell death. Subsequently, the surrounding tissue heals in a natural process.
- While pulsed DC voltages are known to drive electroporation under the right circumstances, the examples of electroporation applications in medicine and delivery methods described in the prior art do not discuss specificity of how electrodes are selected to accomplish the desired ablation. For example, some known catheters and systems include a single multi-electrode catheter in which certain electrodes receive a voltage signal having a first polarity and other electrodes receive a voltage signal having the opposite polarity. Accordingly, to minimize the risk of dielectric breakdown within the catheter, such known catheters typically include substantial insulation (e.g., around the leads), thus increasing the size and limiting the flexibility of the catheter. Some known catheters configured to produce voltage pulses of up to 5 kV include catheter leads having an insulation of as much as 0.2 mm and an overall size of about 14 French (4.67 mm).
- There is a need for selective energy delivery for electroporation and its modulation in various tissue types, as well as pulses that permit rapid action and completion of therapy delivery. This need includes methods and apparatus for placement and therapy delivery from the same device or a set of devices, especially in the context of ablation therapy for cardiac arrhythmias with epicardial catheter devices. There is a need for thin, flexible, atraumatic devices that can, at the same time, effectively deliver high DC voltage electroporation ablation therapy selectively to tissue in regions of interest. Such more selective and effective electroporation delivery methods can broaden the areas of clinical application of electroporation including therapeutic treatment of a variety of cardiac arrhythmias.
- Catheter systems, tools and methods are disclosed for the selective and rapid application of DC voltage to drive electroporation. In some embodiments, an apparatus includes a voltage pulse generator and an electrode controller. The voltage pulse generator is configured to produce a pulsed voltage waveform. The electrode controller is configured to be operably coupled to the voltage pulse generator. The electrode controller includes a first output port and a second output port. The first output port is configured to be operatively coupled to a first medical device including a first set of electrodes, and the second output port is configured to be operatively coupled to a second medical device including a second set of electrodes. The electrode controller includes a selection module and a pulse delivery module. The selection module is configured to select at least a first electrode from the first set of electrodes and identify at least the first electrode as an anode. The selection module is configured to select at least a second electrode from the second set of electrodes and identify at least the second electrode as a cathode. The pulse delivery module is configured to deliver a first output signal having a first polarity and being associated with the pulsed voltage waveform to the first output port for application to the first electrode. The pulse delivery module is configured to deliver a second output signal having a second polarity opposite the first polarity and being associated with the pulsed voltage waveform to the second output port for application to the second electrode.
-
FIG. 1 is a perspective view showing two catheters according to an embodiment, each with multiple electrodes disposed along its shaft and wrapped around a portion of the pulmonary veins and being within the epicardial space of the heart in a subject body such that they form an approximately closed contour around the pulmonary veins. -
FIG. 2 is a schematic illustration of a catheter according to an embodiment, with a multiplicity of electrodes disposed along its shaft, with an electrical lead attached to the inner side of each electrode, and with a magnet located near the distal end of the catheter. -
FIG. 3 illustrates two flexible catheter devices with multiple electrodes disposed along their shafts and positioned to wrap around respective approximate halves of a single closed contour around the pulmonary veins in the epicardial space of the heart, with their distal ends positioned in close proximity. -
FIG. 4 is an illustration of two flexible catheter devices with multiple electrodes disposed along their shafts and positioned to wrap around respective approximate halves of a single closed contour around the pulmonary veins in the epicardial space of the heart, with active electrodes identified according to an embodiment. -
FIG. 5A is a schematic illustration of an irreversible electroporation system according to an embodiment that includes a voltage/signal generator, a controller capable of being configured to apply voltages to selected subsets of electrodes with independent subset selections for anode electrodes on one medical device and cathode electrodes on a second medical device. -
FIG. 5B is a schematic illustration of an irreversible electroporation system according to an embodiment that includes a voltage/signal generator, a controller capable of being configured to apply voltages to selected subsets of electrodes with independent subset selections for anode electrodes on one medical device and cathode electrodes on a second medical device. -
FIG. 6 is an illustration of an ECG waveform showing the refractory periods during atrial and ventricular pacing, and the time windows for irreversible electroporation ablation. -
FIG. 7 is a schematic illustration of a method of selecting subsets of electrodes on two catheters as anodes or cathodes, according to an embodiment, whereby the ablation vector or predominant current density direction vector is selected for ablation. -
FIG. 8 is a schematic illustration of a user interface of the present invention, showing electrodes on two catheters, and buttons for selection or marking of anode electrode subsets and cathode electrode subsets. -
FIG. 9 is a schematic illustration of a user interface according to an embodiment, for selection of anode and cathode electrode subsets, showing a single selected anode electrode on one catheter and two selected cathode electrodes on a second catheter. -
FIG. 10 is a schematic illustration of a waveform generated by the irreversible electroporation system according to an embodiment, showing a balanced square wave. -
FIG. 11 is a schematic illustration of a waveform generated by the irreversible electroporation system according to an embodiment, showing a balanced biphasic square wave. -
FIG. 12 is a schematic illustration of a waveform generated by the irreversible electroporation system according to an embodiment, showing a progressive balanced biphasic square wave. - Systems and methods are disclosed for the selective and rapid application of DC voltage to drive electroporation. In some embodiments, an irreversible electroporation system includes a DC voltage/signal generator and a controller capable of being configured to apply voltages to a selected multiplicity or a subset of electrodes, with anode and cathode subsets being selected independently on distinct medical devices. The controller is additionally capable of applying control inputs whereby selected pairs of anode-cathode subsets of electrodes can be sequentially updated based on a pre-determined sequence.
- In some embodiments, an irreversible electroporation system includes a DC voltage/signal generator and a controller capable of being configured to apply voltages to a selected multiplicity or a subset of electrodes, with independent subset selections for anode and cathode electrode selections on distinct catheter devices respectively. Further, the controller is capable of applying control inputs whereby selected pairs of anode-cathode subsets of electrodes can be sequentially updated based on a pre-determined sequence. The generator can output waveforms that can be selected to generate a sequence of voltage pulses in either monophasic or biphasic forms and with either constant or progressively changing amplitudes.
- In some embodiments, an apparatus includes a voltage pulse generator and an electrode controller. The voltage pulse generator is configured to produce a pulsed voltage waveform. The electrode controller is configured to be operably coupled to the voltage pulse generator. The electrode controller includes a first output port and a second output port. The first output port is configured to be operatively coupled to a first medical device including a first set of electrodes, and the second output port is configured to be operatively coupled to a second medical device including a second set of electrodes. The electrode controller includes a selection module and a pulse delivery module. The selection module is configured to select at least a first electrode from the first set of electrodes and identify at least the first electrode as an anode. The selection module is configured to select at least a second electrode from the second set of electrodes and identify at least the second electrode as a cathode. The pulse delivery module is configured to deliver a first output signal having a first polarity and being associated with the pulsed voltage waveform to the first output port for application to the first electrode. The pulse delivery module is configured to deliver a second output signal having a second polarity opposite the first polarity and being associated with the pulsed voltage waveform to the second output port for application to the second electrode.
- In some embodiments, an apparatus includes a voltage pulse generator and an electrode controller. The voltage pulse generator is configured to produce a pulsed voltage waveform. The electrode controller is configured to be operably coupled to the voltage pulse generator. The electrode controller includes a first output port and a second output port, the first output port configured to be operatively coupled to a first medical device including a first set of electrodes, the second output port configured to be operatively coupled to a second medical device including a second set of electrodes. The electrode controller includes a selection module and a pulse delivery module. The selection module is configured to select a set of anode/cathode pairs, each anode selected being only in the first plurality of electrodes, each cathode selected being only in the second plurality of electrodes. The pulse delivery module is configured to deliver a first output signal having a first polarity and associated with the pulsed voltage waveform to the first output port for application to each anode selected. The pulse delivery module is configured to deliver a second output signal having a second polarity opposite the first polarity and associated with the pulsed voltage waveform to the second output port for application to each cathode selected. The pulse delivery module is configured to deliver the first output signal and the second output signal to the plurality of anode/cathode pairs according to a sequential pattern.
- Methods of control and DC voltage application from a generator capable of selective excitation of sets of electrodes are also disclosed herein. In some embodiments, a method includes identifying, via a selection module of an electrode controller, a set of anode/cathode pairs, each anode selected being only in a first set of electrodes of a first multi-electrode catheter, each cathode selected being only in a second set of electrodes of a second multi-electrode catheter. The first multi-electrode catheter and the second multi-electrode catheter are configured to collectively surround a portion of a heart. A pacing signal is conveyed to a pacing lead configured to be operatively coupled to the heart. The method includes receiving, at a feedback module, an electrocardiograph signal associated with a function of the heart. The method includes delivering, via a pulse delivery module of the electrode controller, a first output signal having a first polarity to each anode selected, and delivering, via the pulse delivery module, a second output signal having a second polarity opposite the first polarity to each cathode selected. The first output signal and the second output signal are delivered according to a sequential pattern.
- In some embodiments, a non-transitory processor readable medium storing code representing instructions to be executed by a processor includes code to cause the processor to identify a set of anode/cathode pairs. Each anode in the plurality of anode/cathode pairs being only in a first set of electrodes of a first multi-electrode catheter. Each cathode in the set of anode/cathode pairs being only in a second set of electrodes of a second multi-electrode catheter. The first multi-electrode catheter and the second multi-electrode catheter are configured to collectively surround a portion of a heart. The code further includes code to convey a pacing signal to a pacing lead configured to be operatively coupled to the heart, and receive an electrocardiograph signal associated with a function of the heart. The code further includes code to deliver, according to a sequential pattern, a first output signal having a first polarity to each anode selected and a second output signal having a second polarity opposite the first polarity to each cathode selected.
- In some embodiments system includes a first flexible catheter including a first set of electrodes and a second flexible catheter including a second set of electrodes. A distal end portion of the first flexible catheter is configured to be coupled to a distal end portion of the second catheter to form a continuous length including the first set of electrodes and the second set of electrodes. The first flexible catheter and the second flexible catheter are configured to deliver a bipolar voltage signal to a target tissue such that a first portion of the bipolar voltage signal having a first polarity is delivered only to the first set of electrodes and a second portion of the bipolar voltage signal having second polarity opposite the first polarity is delivered only to the second set of electrodes.
- As used in this specification, the singular forms “a,” “an” and “the” include plural referents unless the context clearly dictates otherwise. Thus, for example, the term “a member” is intended to mean a single member or a combination of members, “a material” is intended to mean one or more materials, “a processor” is intended to mean a single processor or multiple processors; and “memory” is intended to mean one or more memories, or a combination thereof.
- As used herein, the terms “about” and “approximately” generally mean plus or minus 10% of the value stated. For example, about 0.5 would include 0.45 and 0.55, about 10 would include 9 to 11, about 1000 would include 900 to 1100.
- As shown in
FIG. 1 , in some embodiments a Pulmonary Vein isolation (PV isolation) system includes two ablation catheter devices, one (labeled 5) withdistal end 15 andproximal portion 8, the other (labeled 6) withdistal end 16 andproximal portion 9, each with a multiplicity of electrodes (indicated by dark bands such as those marked as 19) disposed along its length, and where each catheter is wrapped in the epicardial space around a portion of the 10, 11, 12 and 13 of apulmonary veins heart 7 in a subject or patient anatomy, with the 8 and 9 of theproximal portions 5 and 6 extending out and away to eventually emerge from the patient's chest. In some embodiments, the distal ends of the tworespective catheters 5 and 6 havecatheters 15 and 16 respectively that can aid in alignment of the two catheters. Themagnets 5 and 6, and any of the catheters described herein can be similar to the ablation catheters described in PCT Publication No. WO2014/025394, entitled “Catheters, Catheter Systems, and Methods for Puncturing Through a Tissue Structure,” filed on Mar. 14, 2013 (“the '394 PCT Application), which is incorporated herein by reference in its entirety. Theablation catheters 5 and 6 can be disposed about theablation catheters 10, 11, 12 and 13 using any suitable procedure and apparatus. For example, in some embodiments, the ablation catheters can be disposed about thepulmonary veins 10, 11, 12 and 13 and/or thepulmonary veins heart 7 using a puncturing apparatus disposed via a subxiphoid pericardial access location and a using guidewire-based delivery method as described in the '394 PCT Application. Similar methods can be used to deliver and position the two 5 and 6. After thecatheters 8 and 9 of the twoends 5 and 6 extend and emerge out of the patient chest they can be cinched together to effectively hold the catheters in place or in stable positions relative to each other.respective catheters - A DC voltage for electroporation can be applied to subsets of electrodes identified as anodes and cathodes respectively on the two catheters on approximately opposite sides of the closed contour defined by the shapes of the
5 and 6 around the pulmonary veins. The DC voltage is applied in brief pulses sufficient to cause irreversible electroporation and can be in the range of 0.5 kV to 10 kV and more preferably in thecatheters range 1 kV to 2.5 kV, so that a threshold electric field value of around 200 Volts/cm is effectively achieved in the cardiac tissue to be ablated. In some embodiments, the marked or active electrodes on the two catheters can be automatically identified, or manually identified by suitable marking, on an X-ray or fluoroscopic image obtained at an appropriate angulation that permits identification of the geometric distance between anode and cathode electrodes, or their respective centroids. In one embodiment, the DC voltage generator setting for irreversible electroporation is then automatically identified by the electroporation system based on this distance measure. In an alternate embodiment, the DC voltage value is selected directly by a user from a suitable dial, slider, touch screen, or any other user interface. The DC voltage pulse results in a current flowing between the anode and cathode electrodes on opposite sides of the contour defined by the conjoint shapes of the two catheters, with said current flowing through the cardiac wall tissue and through the intervening blood in the cardiac chamber, with the current entering the cardiac tissue from the anode electrodes and returning back through the cathode electrodes. The forward and return current paths (leads) are respectively inside distinct catheters, since all active electrodes on a given catheter are of like polarity. Areas of cardiac wall tissue where the electric field is sufficiently large for irreversible electroporation are ablated during the DC voltage pulse application. -
FIG. 2 is a schematic illustration of a multi-electrode, magnet-tipped catheter according to an embodiment. Thecatheter shaft 801 has a multiplicity of electrodes disposed along an extensive length of catheter at least 5 cm in extent. In some embodiments the metallic electrodes could be poly-metallic in construction, for example, including regions of Titanium and regions of Platinum. AlthoughFIG. 2 shows only four 803, 804, 805 and 806 for clarity, in other embodiments, the number of electrodes can be in the range between 5 and 30, and more preferably in the range between 8 and 18. Each electrode attaches to a corresponding lead, thus as shown inelectrodes FIG. 2 , 803, 804, 805 and 806 attach toelectrodes 813, 814, 815 and 816, respectively.leads - The catheter shaft is made of a flexible polymeric material such as for example Teflon, Nylon or Pebax. Moreover, the
813, 814, 815 and 816 include an insulative covering to ensure that each lead/electrode is electrically isolated from the other leads and electrodes coupled to theleads catheter shaft 801. When the catheter device is used with the systems and methods described herein, all of the 803, 804, 805 and 806 of theelectrodes catheter 801 have the same polarity. Thus, the need for high dielectric strength material separating the leads is not a significant constraint. Accordingly, the insulative material covering each lead can be minimized, and the catheter can be relatively small in diameter. In this manner, the catheter device can have a high degree of flexibility to facilitate the method of surrounding the pulmonary veins as described herein. In some embodiments, for example, the catheter device can have a size in the range of approximately 9 French (3 mm), 8 French (2.67 mm) or even 6 French (2 mm). In some embodiments, the electrode leads of the catheter device can have an insulation thickness of less than about 0.05 mm, less than about 0.01 m, or less than about 0.005 mm. In other embodiments, the electrode leads of the catheter can have an insulation thickness of between about 0.03 mm and about 0.06 mm. - Moreover, by maintaining the voltage for each of the
803, 804, 805 and 806 of theelectrodes catheter 801 at the same polarity, higher voltage levels can be applied to the electrodes of the catheter with minimal risk of dielectric breakdown. In this manner, the catheter device 801 (and the systems and methods described herein) can enhance the efficacy of irreversible electroporation ablation. For example, in some embodiments, the voltage applied to the 803, 804, 805 and 806 can be in the range of 0.5 kV to 2.5 kV; 2.5 kV to 5 kV, and up to 10 kV and more preferably in theelectrodes range 1 kV to 2.5 kV. - As shown in
FIG. 2 , the distal end of thecatheter 801 has a ring-shapedmagnet 809, with the magnet having a magnetization direction that is substantially aligned with the longitudinal axis of the catheter. Themagnet 809 is configured to have a polarity to cooperate with a corresponding magnet from a second catheter to be used in conjunction with thecatheter 801. For example, the 15 and 16 shown respectively at the distal ends of the twomagnets 5 and 6 incatheters FIG. 1 have opposite polarities on their distal faces, so that they attract each other. This attraction can aid in approximate alignment and/or coupling of the catheters. With two distinct catheters, anode and cathode electrodes for voltage application can be selected on distinct devices in accordance with the methods described herein. - Additionally, by using two catheters to deliver a bipolar pulse, but maintaining the voltage for each of the electrodes within each catheter at the same polarity, according to the methods described herein, each of the catheters includes fewer electrodes and few leads than if a single catheter were used to surround the heart. The reduction of the number of leads and electrodes also allows for an overall reduction in the size of the catheter, improvement in the flexibility thereof, and the like.
- In some embodiments, for example, a system includes a first catheter including a first set of electrodes and a second flexible catheter including a second set of electrodes. Each of the catheters can be, for example, the
catheter 801. A distal end portion of the first flexible catheter is configured to be coupled to a distal end portion of the second catheter to form a continuous length including the first set of electrodes and the second set of electrodes. The connection can be via a magnetic coupling device, as shown herein. The first flexible catheter and the second flexible catheter are configured to deliver a bipolar voltage signal to a target tissue such that a first portion of the bipolar voltage signal having a first polarity is delivered only to the first set of electrodes and a second portion of the bipolar voltage signal having second polarity opposite the first polarity is delivered only to the second set of electrodes. -
FIG. 3 shows another example of the placement of afirst catheter 538 and asecond catheter 539, according to an embodiment. Thefirst catheter 538 and thesecond catheter 539 can each be constructed of a small diameter tube covered by multiple metal electrodes. The distal ends of the catheters (544 and 554 respectively) contain magnets that attract and allow for alignment of the devices when their distal ends are in close proximity as indicated byregion 545.Electrodes 543 disposed along thefirst catheter 538 are of a single polarity (for instance, an activated subset of the electrodes would all be anodes), whileelectrodes 553 disposed along thesecond catheter 539 are all of the opposite polarity (in the same example, an activated subset could all be cathodes). Wires are connected to each electrode in the anode and cathode catheters, indicated by collective anode leads 542 and collective cathode leads 552 respectively. Thus, wires of opposite polarity are not in the same catheter, thereby reducing the possibility of dielectric breakdown at high voltage, as discussed above. Furthermore, when it is desired to reduce the catheter diameter and the number of leads within a given catheter, it may also be advantageous to use two distinct catheters, with the pair of catheters surround and/or substantially enclosing the pulmonary veins and with their distal ends closely abutting. Reduced diameter catheters can be significantly more flexible and a smaller number of leads in a given catheter (resulting in a smaller catheter diameter) can be advantageous in this regard. While in this example the two catheters are navigated and coupled magnetically, those skilled in the art could implement other means of alignment and positioning of the catheters without departing from the scope of the teachings herein. - The illustration in
FIG. 4 shows thefirst catheter 538 and thesecond catheter 539 having proximal leads 542 and 552, respectively, and having distal ends 544 and 554, respectively. In accordance with the systems and methods described herein, the a singleactive anode electrode 604 is selected on thesecond catheter 539, and two 601 and 602 are selected on theactive cathode electrodes first catheter 538. A DC voltage for irreversible electroporation ablation can then be applied across the selected anode-cathode electrodes. - A schematic diagram of an electroporation system according to an embodiment is shown in
FIG. 5A . The system includes a DC voltage/signal generator 23 that is driven by acontroller unit 21. Thecontroller unit 21 interfaces with acomputer device 24 by means of a two-way communication link 29. The controller interface can act as a multiplexer unit and perform channel selection and routing functions for applying DC voltages to appropriate electrodes that have been selected by a user or by thecomputer 24. The controller can apply the voltages via a multiplicity of leads to afirst catheter device 22, as well as asecond catheter device 122. Active electrodes can be selected on afirst catheter device 22 with one polarity, and likewise active electrodes can be selected on asecond catheter device 122 with the opposite polarity. - In some embodiments, one or more leads from the
controller 21 could also carry pacing signals to drive pacing of the heart through a separate pacing device (not shown). The catheter devices can also send back information such as ECG recordings or data from other sensors back to thecontroller 21, possibly on separate leads. While theDC voltage generator 23 sends a DC voltage to thecontroller 21 throughleads 27, the voltage generator is driven by control and timinginputs 28 from thecontroller unit 21. - As shown in
FIG. 6 , given atrial or ventricular pacing inputs to the heart, the resultingECG waveform 32 has appropriate respective 33 and 34 respectively, during which there are suitable time windows for application of irreversible electroporation as indicated by 35 and 36. The application of cardiac pacing results in a periodic, well-controlled sequence of electroporation time windows. Typically, this time window is of the order of hundreds of microseconds to about a millisecond or more. During this window, multiple DC voltage pulses can be applied to ensure that sufficient tissue ablation has occurred. The user can repeat the delivery of irreversible electroporation over several successive cardiac cycles for further confidence. Thus, in some embodiments, a feedback module (e.g., feedback module 905) can receive the electrocardiograph signal, and a pulse delivery module (e.g., pulse delivery module 908) can deliver the output signal to the subset of electrodes during a time window associated with at least one a pacing signal or the electrocardiograph signal.refractory time intervals - In one embodiment, the ablation controller and signal generator can be mounted on a rolling trolley, and the user can control the device using a touchscreen interface that is in the sterile field. The touchscreen can be for example an LCD touchscreen in a plastic housing mountable to a standard medical rail or post and can be used to select the electrodes for ablation and to ready the device to fire. The interface can for example be covered with a clear sterile plastic drape. The operator can select the number of electrodes involved in an automated sequence. The touch screen graphically shows the catheters that are attached to the controller. In one embodiment the operator can select electrodes from the touchscreen with appropriate graphical buttons. The operator can also select the pacing stimulus protocol (either internally generated or externally triggered) from the interface. Once pacing is enabled, and the ablation sequence is selected, the operator can initiate or verify pacing. Once the operator verifies that the heart is being paced, the ablation sequence can be initiated by holding down a hand-held trigger button that is in the sterile field. The hand-held trigger button can be illuminated red to indicate that the device is “armed” and ready to ablate. The trigger button can be compatible for use in a sterile field and when attached to the controller can be illuminated a different color, for example white. When the device is firing, the trigger button flashes in sequence with the pulse delivery in a specific color such as red. The waveform of each delivered pulse is displayed on the touchscreen interface. A graphic representation of the pre and post impedance between electrodes involved in the sequence can also be shown on the interface, and this data can be exported for file storage.
- In one embodiment, an impedance map can be generated based on voltage and current recordings across anode-cathode pairs or sets of electrodes (anodes and cathodes respectively being on distinct catheters), and an appropriate set of electrodes that are best suited for ablation delivery in a given region can be selected based on the impedance map or measurements, either manually by a user or automatically by the system. Such an impedance map can be produced, for example, by the
feedback module 905, or any other suitable portion of theelectrode controller 900. For example, if the impedance across an anode/cathode combination of electrodes is a relatively low value (for example, less than 25 Ohms), at a given voltage the said combination would result in relatively large currents in the tissue and power dissipation in tissue. In such circumstances, this electrode combination would then be ruled out for ablation due to safety considerations (e.g., via the selection module 912), and alternate electrode combinations would be sought by the user. In a preferred embodiment, a pre-determined range of impedance values, for example 30 Ohms to 300 Ohms, could be used as an allowed impedance range within which it is deemed safe to ablate. Thus, in some embodiments, an electrode controller can automatically determine a subset of electrodes to which voltage pulses should be applied. - The waveforms for the various electrodes can be displayed and recorded on the case monitor and simultaneously outputted to a standard connection for any electrophysiology (EP) data acquisition system. With the high voltages involved with the device, the outputs to the EP data acquisition system needs to be protected from voltage and/or current surges. The waveforms acquired internally can be used to autonomously calculate impedances between each electrode pair. The waveform amplitude, period, duty cycle, and delay can all be modified, for example via a suitable Ethernet connection. Pacing for the heart is controlled by the device and outputted to the pacing leads and a protected pacing circuit output for monitoring by a lab.
- While a touchscreen interface is one preferred embodiment, other user interfaces can be used by a user to control the system such as a graphical display on a laptop or monitor display controlled by a standard computer mouse or joystick.
FIG. 7 shows a schematic rendering of a portion of the user interface of the electroporation system. The graphic shown in the FIG. represents a specific choice of electrode subsets for anode and cathode selection. The two PV isolation ablation catheters in the FIG. are represented by strings of numbered electrodes as indicated respectively by 591 and 592, wrapped around thearea 590 of the pulmonary veins represented by the gray region in this schematic diagram for ease of user visualization. The 591 and 592 havecatheters 651 and 652 respectively that connect to a controller or interface unit as described earlier. Referring to the figure, theproximal leads 595 and 596 represent approximate current density vectors, with one end at the cathodes and the other end at the anodes; in this figure, the three electrodes marked 601 and 602 are cathodes, and the single electrode marked 604 is the anode. It is apparent fromarrows FIG. 7 that the user can select various subsets of electrodes (respectively on distinct catheters) as cathode or anode, depending on the region to be ablated along the length of the contour around the pulmonary veins represented by the two catheters. In one embodiment, the user can make one selection of cathode and anode subsets, and the system can take this selection as input to generate an ablation sequence that moves around the ring or contour defined by the shapes of the two PV isolation catheters, for example moving clockwise at each step with a one-electrode displacement. In this manner, the pair of cathode and anode electrode subsets can be sequentially updated for ablation purposes, so that if there are N/2 electrodes on each catheter, after N updates the entire contour has been updated such that the current arrows shown as 595 and 596 have swept once around the contour completely. - In some cases, the portion of one of the PV isolation catheters with electrodes may be longer than needed to wrap around a given patient's pulmonary veins; in this event, a smaller number of electrodes is sufficient to wrap around the contour of the pulmonary veins. These define the number of “active” electrodes to be used in the ablation process.
- In a some embodiments, the system (any of the generators and controllers described herein) can deliver rectangular-wave pulses with a peak maximum voltage of about 5 kV into a load with an impedance in the range of 30 Ohm to 3000 Ohm for a maximum duration of 200 μs, with a 100 μs maximum duration being still more preferred. Pulses can be delivered in a multiplexed and synchronized manner to a multi-electrode catheter inside the body with a duty cycle of up to 50% (for short bursts). The pulses can generally be delivered in bursts, such as for example a sequence of between 2 and 10 pulses interrupted by pauses of between 1 ms and 1000 ms. The multiplexer controller is capable of running an automated sequence to deliver the impulses/impulse trains (from the DC voltage signal/impulse generator) to the tissue target within the body. The controller system is capable of switching between subsets/nodes of electrodes located on the single-use catheters. Further, the controller can measure voltage and current and tabulate impedances in each electrode configuration (for display, planning, and internal diagnostic analysis). It can also generate two channels of cardiac pacing stimulus output, and is capable of synchronizing impulse delivery with the internally generated cardiac pacing and/or an external trigger signal. In one embodiment, it can provide sensing output/connection for access to bio potentials emanating from each electrode connected to the system (with connectivity characteristics being compatible with standard electrophysiological laboratory data acquisition equipment).
- In some embodiments, the controller (e.g., the electrode controller 900) can automatically “recognize” each of the two single-use disposable catheters when it is connected to the controller output (prompting internal diagnostics and user interface configuration options). The controller can have at least two unique output connector ports (e.g., the
first output port 940 and the second output port 942) to accommodate up to at least two catheters at once. The controller device can function as long as at least two recognized catheters are attached to it. In some embodiments, the controller can have several sequence configurations that provide the operator with at least some variety of programming options. In one configuration, the controller can switch electrode configurations of a bipolar set of electrodes (cathodes and anodes respectively on distinct catheters) sequentially in a clockwise manner (for example, starting at a given step, in the next step of the algorithm, the next cathode electrode on one catheter and the next anode electrode on the other catheter are automatically selected, timed to the synchronizing trigger), with the two catheters and their electrodes arranged in a quasi-circumference around the target. Thus in the first sequence, pulse delivery occurs so that the approximate vector of current density changes as the automated sequencing of the controller switches “on” and “off” between different electrodes surrounding the tissue target sequence. The current density vectors generally cross the target tissue but in some configurations the current density could be approximately tangential to the target. In a second sequence configuration, the impulses are delivered to user-selected electrode subsets of catheters that are connected to the device (the vector of current density does not change with each synchronized delivery). The user can also configure the controller to deliver up to 2 channels of pacing stimulus to electrodes connected to the device output. The user can control the application of DC voltage with a single handheld switch. A sterile catheter or catheters can be connected to the voltage output of the generator via a connector cable that can be delivered to the sterile field. In one embodiment, the user activates the device with a touch screen interface (that can be protected with a single-use sterile transparent disposable cover commonly available in the catheter lab setting). The generator can remain in a standby mode until the user is ready to apply pulses at which point the user/assistant can put the generator into a ready mode via the touchscreen interface. Subsequently the user can select the sequence, the active electrodes, and the cardiac pacing parameters. - Once the catheters have been advanced to or around the cardiac target, the user can initiate electrically pacing the heart (using a pacing stimulus generated by the ablation controller or an external source synchronized to the ablation system). The operator verifies that the heart is being paced and uses the hand-held trigger button to apply the synchronized bursts of high voltage pulses. The system can continue delivering the burst pulse train with each cardiac cycle as long as the operator is holding down a suitable “fire” button or switch. During the application of the pulses, the generator output is synchronized with the heart rhythm so that short bursts are delivered at a pre-specified interval from the paced stimulus. When the train of pulses is complete, the pacing continues until the operator discontinues pacing.
-
FIG. 8 shows a portion of a user interface of the electroporation system for selection (with graphical button 701) of anode and cathode electrodes, with two catheters connected to the system. One of the catheters is aPV isolation catheter 591 while the other is aPV isolation catheter 592, with their leads schematically indicated by 651 and 652 respectively. The 703 and 704 can enable the selection of marked electrode subsets on the catheters as respectively anode or cathode with a “Continue”buttons button 706. Once the selection is made, the appropriate electrodes are colored differently to indicate anode or cathode electrodes as shown marked respectively as 719 and 721 on 592 and 591 respectively incatheters FIG. 9 . - The controller and generator can output waveforms that can be selected to generate a sequence of voltage pulses in either monophasic or biphasic forms and with either constant or progressively changing amplitudes.
FIG. 10 shows a rectangular wave pulse train where thepulses 101 have a uniform height or maximum voltage.FIG. 11 shows an example of a balanced biphasic rectangular pulse train, where each positive voltage pulse such as 103 is immediately followed by a negative voltage pulse such as 104 of equal amplitude and opposite sign. While in this example the biphasic pulses are balanced with equal amplitudes of the positive and negative voltages, in other embodiments an unbalanced biphasic waveform could also be used as may be convenient for a given application. - Yet another example of a waveform or pulse shape that can be generated by the system is illustrated in
FIG. 12 , which shows a progressive balanced rectangular pulse train, where each distinct biphasic pulse has balanced or equal-amplitude positive and negative voltages, but each pulse such as 107 is larger in amplitude than itsimmediate predecessor 106. Other variations such as a progressive unbalanced rectangular pulse train, or indeed a wide variety of other variations of pulse amplitude with respect to time can be conceived and implemented by those skilled in the art based on the teachings herein. - The time duration of each irreversible electroporation rectangular voltage pulse could lie in the range from 1 nanosecond to 10 milliseconds, with the
range 10 microseconds to 1 millisecond being more preferable and the range 50 microseconds to 300 microseconds being still more preferable. The time interval between successive pulses of a pulse train could be in the range of 10 microseconds to 1 millisecond, with the range 50 microseconds to 300 microseconds being more preferable. The number of pulses applied in a single pulse train (with delays between individual pulses lying in the ranges just mentioned) can range from 1 to 100, with therange 1 to 10 being more preferable. As described in the foregoing, a pulse train can be driven by a user-controlled switch or button, in one embodiment preferably mounted on a hand-held joystick-like device. In one mode of operation a pulse train can be generated for every push of such a control button, while in an alternate mode of operation pulse trains can be generated repeatedly during the refractory periods of a set of successive cardiac cycles, for as long as the user-controlled switch or button is engaged by the user. - In some embodiments, a method includes identifying, via a selection module of an electrode controller, a set of anode/cathode pairs. Each anode selected in the set of anode/cathode pairs is only in a first set of electrodes of a first multi-electrode catheter. Each cathode selected in the plurality of anode/cathode pairs is only in a second set of electrodes of a second multi-electrode catheter. The first multi-electrode catheter and the second multi-electrode catheter are configured to collectively surround a portion of a heart, as described herein. In some embodiments, the identifying can be based on a predetermined schedule of electrodes. In yet other embodiments, the identifying can be performed automatically based on an impedance measurement or map as described herein.
- The method further includes conveying a pacing signal to a pacing lead configured to be operatively coupled to the heart, and receiving, at a feedback module of the electrode controller, an electrocardiograph signal associated with a function of the heart.
- The method further includes delivering, via a pulse delivery module of the electrode controller, a first output signal having a first polarity to each anode selected. The method further includes delivering, via the pulse delivery module, a second output signal having a second polarity to each cathode selected. The first output signal and the second output signal being delivered according to a sequential pattern.
- Some embodiments described herein relate to a computer storage product with a non-transitory computer-readable medium (also can be referred to as a non-transitory processor-readable medium) having instructions or computer code thereon for performing various computer-implemented operations. The computer-readable medium (or processor-readable medium) is non-transitory in the sense that it does not include transitory propagating signals per se (e.g., a propagating electromagnetic wave carrying information on a transmission medium such as space or a cable). The media and computer code (also can be referred to as code) may be those designed and constructed for the specific purpose or purposes. Examples of non-transitory computer-readable media include, but are not limited to: magnetic storage media such as hard disks, floppy disks, and magnetic tape; optical storage media such as Compact Disc/Digital Video Discs (CD/DVDs), Compact Disc-Read Only Memories (CD-ROMs), and holographic devices; magneto-optical storage media such as optical disks; carrier wave signal processing modules; and hardware devices that are specially configured to store and execute program code, such as Application-Specific Integrated Circuits (ASICs), Programmable Logic Devices (PLDs), Read-Only Memory (ROM) and Random-Access Memory (RAM) devices.
- Examples of computer code include, but are not limited to, micro-code or micro-instructions, machine instructions, such as produced by a compiler, code used to produce a web service, and files containing higher-level instructions that are executed by a computer using an interpreter. For example, embodiments may be implemented using imperative programming languages (e.g., C, Fortran, etc.), functional programming languages (Haskell, Erlang, etc.), logical programming languages (e.g., Prolog), object-oriented programming languages (e.g., Java, C++, etc.) or other suitable programming languages and/or development tools. Additional examples of computer code include, but are not limited to, control signals, encrypted code, and compressed code.
- While various specific examples and embodiments of systems and tools for selective tissue ablation with irreversible electroporation were described in the foregoing for illustrative and exemplary purposes, it should be clear that a wide variety of variations and alternate embodiments could be conceived or constructed by those skilled in the art based on the teachings herein. While specific methods of control and DC voltage application from a generator capable of selective excitation of sets of electrodes were disclosed, persons skilled in the art would recognize that any of a wide variety of other control or user input methods and methods of electrode subset selection etc. can be implemented without departing from the scope of the present invention. Likewise, while the foregoing described a range of specific tools or devices for more effective and selective DC voltage application for irreversible electroporation through ionic fluid irrigation and ultrasonic agitation, including insulating balloon constructions, focal ablation tools, and a basket catheter with a multiplicity of, other device constructions or variations could be implemented by one skilled in the art by employing the principles and teachings disclosed herein without departing from the scope of the present invention, in the treatment of cardiac arrhythmias, in intravascular applications, or a variety of other medical applications.
- Furthermore, while the present disclosure describes specific embodiments and tools involving irrigation with saline fluids and the use of temperature to selectively ablate tissue by taking advantage of the temperature-dependence of the threshold of irreversible electroporation, it should be clear to one skilled in the art that a variety of methods and devices for steady fluid delivery, or for tissue heating through the delivery of focused kinetic energy or electromagnetic radiation could be implemented utilizing the methods and principles taught herein without departing from the scope of the present invention.
- Where schematics and/or embodiments described above indicate certain components arranged in certain orientations or positions, the arrangement of components may be modified. For example, although the
controller 900 is shown as optionally including thepacing module 902, in other embodiments, thecontroller 900 can interface with a separate pacing module. For example, although thecontroller 900 is shown as optionally including thefeedback module 905, in other embodiments, thecontroller 900 can interface with a separate feedback module. Similarly, where methods and/or events described above indicate certain events and/or procedures occurring in certain order, the ordering of certain events and/or procedures may be modified. - Although various embodiments have been described as having particular features and/or combinations of components, other embodiments are possible having a combination of any features and/or components from any of embodiments as discussed above.
Claims (14)
Priority Applications (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US15/795,075 US20180042675A1 (en) | 2014-05-16 | 2017-10-26 | Methods and apparatus for multi-catheter tissue ablation |
| US17/207,053 US12137968B2 (en) | 2014-05-16 | 2021-03-19 | Methods and apparatus for multi-catheter tissue ablation |
| US18/943,623 US20250064511A1 (en) | 2014-05-16 | 2024-11-11 | Methods and apparatus for multi-catheter tissue ablation |
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201461996855P | 2014-05-16 | 2014-05-16 | |
| PCT/US2015/031086 WO2015175944A1 (en) | 2014-05-16 | 2015-05-15 | Methods and apparatus for multi-catheter tissue ablation |
| US15/341,523 US20170065340A1 (en) | 2014-05-16 | 2016-11-02 | Methods and apparatus for multi-catheter tissue ablation |
| US15/795,075 US20180042675A1 (en) | 2014-05-16 | 2017-10-26 | Methods and apparatus for multi-catheter tissue ablation |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US15/341,523 Continuation US20170065340A1 (en) | 2014-05-16 | 2016-11-02 | Methods and apparatus for multi-catheter tissue ablation |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US17/207,053 Continuation US12137968B2 (en) | 2014-05-16 | 2021-03-19 | Methods and apparatus for multi-catheter tissue ablation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| US20180042675A1 true US20180042675A1 (en) | 2018-02-15 |
Family
ID=53276301
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US15/341,523 Abandoned US20170065340A1 (en) | 2014-05-16 | 2016-11-02 | Methods and apparatus for multi-catheter tissue ablation |
| US15/795,075 Abandoned US20180042675A1 (en) | 2014-05-16 | 2017-10-26 | Methods and apparatus for multi-catheter tissue ablation |
| US17/207,053 Active 2036-04-04 US12137968B2 (en) | 2014-05-16 | 2021-03-19 | Methods and apparatus for multi-catheter tissue ablation |
| US18/943,623 Pending US20250064511A1 (en) | 2014-05-16 | 2024-11-11 | Methods and apparatus for multi-catheter tissue ablation |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US15/341,523 Abandoned US20170065340A1 (en) | 2014-05-16 | 2016-11-02 | Methods and apparatus for multi-catheter tissue ablation |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US17/207,053 Active 2036-04-04 US12137968B2 (en) | 2014-05-16 | 2021-03-19 | Methods and apparatus for multi-catheter tissue ablation |
| US18/943,623 Pending US20250064511A1 (en) | 2014-05-16 | 2024-11-11 | Methods and apparatus for multi-catheter tissue ablation |
Country Status (3)
| Country | Link |
|---|---|
| US (4) | US20170065340A1 (en) |
| EP (1) | EP3142584A1 (en) |
| WO (1) | WO2015175944A1 (en) |
Cited By (41)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9987081B1 (en) | 2017-04-27 | 2018-06-05 | Iowa Approach, Inc. | Systems, devices, and methods for signal generation |
| US10130423B1 (en) | 2017-07-06 | 2018-11-20 | Farapulse, Inc. | Systems, devices, and methods for focal ablation |
| US10172673B2 (en) | 2016-01-05 | 2019-01-08 | Farapulse, Inc. | Systems devices, and methods for delivery of pulsed electric field ablative energy to endocardial tissue |
| US10322286B2 (en) | 2016-01-05 | 2019-06-18 | Farapulse, Inc. | Systems, apparatuses and methods for delivery of ablative energy to tissue |
| US10368936B2 (en) | 2014-11-17 | 2019-08-06 | Kardium Inc. | Systems and methods for selecting, activating, or selecting and activating transducers |
| US10433906B2 (en) | 2014-06-12 | 2019-10-08 | Farapulse, Inc. | Method and apparatus for rapid and selective transurethral tissue ablation |
| US10470826B2 (en) | 2012-05-21 | 2019-11-12 | Kardium Inc. | Systems and methods for selecting, activating, or selecting and activating transducers |
| US10499986B2 (en) | 2007-11-16 | 2019-12-10 | Kardium Inc. | Medical device for use in bodily lumens, for example an atrium |
| US10507302B2 (en) | 2016-06-16 | 2019-12-17 | Farapulse, Inc. | Systems, apparatuses, and methods for guide wire delivery |
| US10512505B2 (en) | 2018-05-07 | 2019-12-24 | Farapulse, Inc. | Systems, apparatuses and methods for delivery of ablative energy to tissue |
| US10517672B2 (en) | 2014-01-06 | 2019-12-31 | Farapulse, Inc. | Apparatus and methods for renal denervation ablation |
| US10568576B2 (en) | 2012-05-21 | 2020-02-25 | Kardium Inc. | Systems and methods for activating transducers |
| US10617867B2 (en) | 2017-04-28 | 2020-04-14 | Farapulse, Inc. | Systems, devices, and methods for delivery of pulsed electric field ablative energy to esophageal tissue |
| US10624693B2 (en) | 2014-06-12 | 2020-04-21 | Farapulse, Inc. | Method and apparatus for rapid and selective tissue ablation with cooling |
| US10625080B1 (en) | 2019-09-17 | 2020-04-21 | Farapulse, Inc. | Systems, apparatuses, and methods for detecting ectopic electrocardiogram signals during pulsed electric field ablation |
| US10660702B2 (en) | 2016-01-05 | 2020-05-26 | Farapulse, Inc. | Systems, devices, and methods for focal ablation |
| US10687892B2 (en) | 2018-09-20 | 2020-06-23 | Farapulse, Inc. | Systems, apparatuses, and methods for delivery of pulsed electric field ablative energy to endocardial tissue |
| US10702337B2 (en) | 2016-06-27 | 2020-07-07 | Galary, Inc. | Methods, apparatuses, and systems for the treatment of pulmonary disorders |
| US10722184B2 (en) | 2014-11-17 | 2020-07-28 | Kardium Inc. | Systems and methods for selecting, activating, or selecting and activating transducers |
| US10820941B2 (en) | 2006-06-28 | 2020-11-03 | Kardium Inc. | Apparatus and method for intra-cardiac mapping and ablation |
| US10827977B2 (en) | 2012-05-21 | 2020-11-10 | Kardium Inc. | Systems and methods for activating transducers |
| US10835314B2 (en) | 2014-10-14 | 2020-11-17 | Farapulse, Inc. | Method and apparatus for rapid and safe pulmonary vein cardiac ablation |
| US10842572B1 (en) | 2019-11-25 | 2020-11-24 | Farapulse, Inc. | Methods, systems, and apparatuses for tracking ablation devices and generating lesion lines |
| US10893905B2 (en) | 2017-09-12 | 2021-01-19 | Farapulse, Inc. | Systems, apparatuses, and methods for ventricular focal ablation |
| US11020180B2 (en) | 2018-05-07 | 2021-06-01 | Farapulse, Inc. | Epicardial ablation catheter |
| US11033236B2 (en) | 2018-05-07 | 2021-06-15 | Farapulse, Inc. | Systems, apparatuses, and methods for filtering high voltage noise induced by pulsed electric field ablation |
| US11065047B2 (en) | 2019-11-20 | 2021-07-20 | Farapulse, Inc. | Systems, apparatuses, and methods for protecting electronic components from high power noise induced by high voltage pulses |
| US11259869B2 (en) | 2014-05-07 | 2022-03-01 | Farapulse, Inc. | Methods and apparatus for selective tissue ablation |
| US11389232B2 (en) | 2006-06-28 | 2022-07-19 | Kardium Inc. | Apparatus and method for intra-cardiac mapping and ablation |
| US11426573B2 (en) | 2012-08-09 | 2022-08-30 | University Of Iowa Research Foundation | Catheters, catheter systems, and methods for puncturing through a tissue structure and ablating a tissue region |
| US11497541B2 (en) | 2019-11-20 | 2022-11-15 | Boston Scientific Scimed, Inc. | Systems, apparatuses, and methods for protecting electronic components from high power noise induced by high voltage pulses |
| US12042208B2 (en) | 2018-05-03 | 2024-07-23 | Boston Scientific Scimed, Inc. | Systems, devices, and methods for ablation using surgical clamps |
| US12137968B2 (en) | 2014-05-16 | 2024-11-12 | Boston Scientific Scimed, Inc. | Methods and apparatus for multi-catheter tissue ablation |
| US12144541B2 (en) | 2016-01-05 | 2024-11-19 | Boston Scientific Scimed, Inc. | Systems, apparatuses and methods for delivery of ablative energy to tissue |
| US12150700B2 (en) | 2015-08-06 | 2024-11-26 | Medtronic, Inc. | Cardiac pulsed field ablation |
| US12268437B2 (en) | 2020-07-24 | 2025-04-08 | Boston Scientific Scimed, Inc. | Electric field application for single shot cardiac ablation by irreversible electroporation |
| US12295637B2 (en) | 2018-02-08 | 2025-05-13 | Boston Scientific Scimed, Inc. | Method and apparatus for controlled delivery of pulsed electric field ablative energy to tissue |
| US12310652B2 (en) | 2020-07-24 | 2025-05-27 | Boston Scientific Scimed, Inc. | Hybrid electroporation ablation catheter |
| US12343071B2 (en) | 2021-01-27 | 2025-07-01 | Boston Scientific Scimed, Inc | Voltage controlled pulse sequences for irreversible electroporation ablations |
| US12349964B2 (en) | 2020-09-30 | 2025-07-08 | Boston Scientific Scimed, Inc. | Pretreatment waveform for irreversible electroporation |
| US12403305B2 (en) | 2016-06-27 | 2025-09-02 | Galvanize Therapeutics, Inc. | Immunostimulation in the treatment of viral infection |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20190110704A1 (en) * | 2017-10-06 | 2019-04-18 | Symap Medical (Suzhou), Limited | System and method for mapping the functional nerves innervating the wall of arteries, 3-d mapping and catheters for same |
| EP3399931B1 (en) * | 2016-01-05 | 2022-04-06 | Farapulse, Inc. | System for delivery of ablative energy to tissue |
| US11737817B2 (en) | 2016-04-18 | 2023-08-29 | Boston Scientific Scimed, Inc. | Methods and systems for controlling energy delivery in medical devices |
| EP3884895B1 (en) * | 2016-11-29 | 2022-10-05 | St. Jude Medical, Cardiology Division, Inc. | Electroporation systems and catheters for electroporation systems |
| US10569081B2 (en) | 2017-03-03 | 2020-02-25 | Medtronic, Inc. | Stacked potential electroporation |
| CN110461262B (en) * | 2017-04-10 | 2023-01-06 | 圣犹达医疗用品心脏病学部门有限公司 | Electroporation system and method of stimulating catheter |
| EP3459480A1 (en) * | 2017-09-21 | 2019-03-27 | National University of Ireland, Galway | Apparatus for localising an electrical field |
| JP6778973B2 (en) * | 2019-04-24 | 2020-11-04 | 株式会社Mitテクノロジー | Drug administration device, its operation method, and supporter |
| US20200397505A1 (en) * | 2019-06-19 | 2020-12-24 | Farapulse, Inc. | Systems, devices, and methods for focal ablation |
| US11540877B2 (en) * | 2019-12-03 | 2023-01-03 | Biosense Webster (Israel) Ltd. | Pulse generator for irreversible electroporation |
| US20210169568A1 (en) * | 2019-12-09 | 2021-06-10 | Biosense Webster (Israel) Ltd. | Oriented irreversible-electroporation (ire) pulses to compensate for cell size and orientation |
| US12076071B2 (en) | 2020-08-14 | 2024-09-03 | Kardium Inc. | Systems and methods for treating tissue with pulsed field ablation |
| CR20230475A (en) | 2021-04-07 | 2024-01-19 | Btl Medical Dev A S | Pulsed field ablation device and method |
| EP4366637B1 (en) | 2021-07-06 | 2025-06-25 | BTL Medical Development A.S. | Pulsed field ablation device |
| CN113768612B (en) * | 2021-07-30 | 2023-12-22 | 苏州艾科脉医疗技术有限公司 | High voltage transmitting circuit for catheter and ablation instrument |
| CN119095544A (en) * | 2022-04-26 | 2024-12-06 | Crc Ep公司 | Mapping and ablation system for linear pulsed field cardiac ablation |
| IL319700A (en) | 2022-10-05 | 2025-05-01 | Btl Medical Dev A S | Pulsed field ablation device and method |
Citations (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4200104A (en) * | 1977-11-17 | 1980-04-29 | Valleylab, Inc. | Contact area measurement apparatus for use in electrosurgery |
| US5242441A (en) * | 1992-02-24 | 1993-09-07 | Boaz Avitall | Deflectable catheter with rotatable tip electrode |
| US5578040A (en) * | 1994-06-14 | 1996-11-26 | Smith; Albert C. | Ocular repair system and apparatus |
| US5836874A (en) * | 1996-04-08 | 1998-11-17 | Ep Technologies, Inc. | Multi-function electrode structures for electrically analyzing and heating body tissue |
| US5863291A (en) * | 1996-04-08 | 1999-01-26 | Cardima, Inc. | Linear ablation assembly |
| US20030130711A1 (en) * | 2001-09-28 | 2003-07-10 | Pearson Robert M. | Impedance controlled tissue ablation apparatus and method |
| US20040087939A1 (en) * | 1993-05-10 | 2004-05-06 | Arthrocare Corporation | Methods for electrosurgical tissue treatment between spaced apart electrodes |
| US6805128B1 (en) * | 1996-10-22 | 2004-10-19 | Epicor Medical, Inc. | Apparatus and method for ablating tissue |
| US20060293731A1 (en) * | 2005-06-24 | 2006-12-28 | Boris Rubinsky | Methods and systems for treating tumors using electroporation |
| US20090062788A1 (en) * | 2007-08-31 | 2009-03-05 | Long Gary L | Electrical ablation surgical instruments |
| US20090076500A1 (en) * | 2007-09-14 | 2009-03-19 | Lazure Technologies, Llc | Multi-tine probe and treatment by activation of opposing tines |
| US20090138009A1 (en) * | 2007-11-05 | 2009-05-28 | Viswanathan Raju R | Magnetically guided energy delivery apparatus |
| US20110130708A1 (en) * | 2009-05-13 | 2011-06-02 | Minnow Medical, Inc. | Directional Delivery of Energy and Bioactives |
| US20120095459A1 (en) * | 2010-10-13 | 2012-04-19 | Peter Callas | System and Method for Electrically Ablating Tissue of a Patient |
Family Cites Families (561)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4470407A (en) | 1982-03-11 | 1984-09-11 | Laserscope, Inc. | Endoscopic device |
| US4739759A (en) | 1985-02-26 | 1988-04-26 | Concept, Inc. | Microprocessor controlled electrosurgical generator |
| US5547467A (en) | 1988-01-21 | 1996-08-20 | Massachusettes Institute Of Technology | Method for rapid temporal control of molecular transport across tissue |
| US5344435A (en) | 1988-07-28 | 1994-09-06 | Bsd Medical Corporation | Urethral inserted applicator prostate hyperthermia |
| FR2639238B1 (en) | 1988-11-21 | 1991-02-22 | Technomed Int Sa | APPARATUS FOR SURGICAL TREATMENT OF TISSUES BY HYPERTHERMIA, PREFERABLY THE PROSTATE, COMPRISING MEANS OF THERMAL PROTECTION COMPRISING PREFERABLY RADIOREFLECTIVE SCREEN MEANS |
| US5257635A (en) | 1988-11-25 | 1993-11-02 | Sensor Electronics, Inc. | Electrical heating catheter |
| US5749914A (en) | 1989-01-06 | 1998-05-12 | Advanced Coronary Intervention | Catheter for obstructed stent |
| US5342301A (en) | 1992-08-13 | 1994-08-30 | Advanced Polymers Incorporated | Multi-lumen balloons and catheters made therewith |
| WO1992021285A1 (en) | 1991-05-24 | 1992-12-10 | Ep Technologies, Inc. | Combination monophasic action potential/ablation catheter and high-performance filter system |
| US6029671A (en) | 1991-07-16 | 2000-02-29 | Heartport, Inc. | System and methods for performing endovascular procedures |
| US5697281A (en) | 1991-10-09 | 1997-12-16 | Arthrocare Corporation | System and method for electrosurgical cutting and ablation |
| US5524338A (en) | 1991-10-22 | 1996-06-11 | Pi Medical Corporation | Method of making implantable microelectrode |
| US5304214A (en) | 1992-01-21 | 1994-04-19 | Med Institute, Inc. | Transurethral ablation catheter |
| US5306296A (en) | 1992-08-21 | 1994-04-26 | Medtronic, Inc. | Annuloplasty and suture rings |
| US5281213A (en) | 1992-04-16 | 1994-01-25 | Implemed, Inc. | Catheter for ice mapping and ablation |
| US5443463A (en) | 1992-05-01 | 1995-08-22 | Vesta Medical, Inc. | Coagulating forceps |
| US20050222632A1 (en) | 1992-05-17 | 2005-10-06 | Obino Stan F | Device and method for the treatment of cardiac disorders |
| US5341807A (en) | 1992-06-30 | 1994-08-30 | American Cardiac Ablation Co., Inc. | Ablation catheter positioning system |
| US5662108A (en) | 1992-09-23 | 1997-09-02 | Endocardial Solutions, Inc. | Electrophysiology mapping system |
| US5313943A (en) | 1992-09-25 | 1994-05-24 | Ep Technologies, Inc. | Catheters and methods for performing cardiac diagnosis and treatment |
| US5700243A (en) | 1992-10-30 | 1997-12-23 | Pdt Systems, Inc. | Balloon perfusion catheter |
| US6068653A (en) | 1992-11-13 | 2000-05-30 | Scimed Life Systems, Inc. | Electrophysiology catheter device |
| US5334193A (en) | 1992-11-13 | 1994-08-02 | American Cardiac Ablation Co., Inc. | Fluid cooled ablation catheter |
| US5545161A (en) | 1992-12-01 | 1996-08-13 | Cardiac Pathways Corporation | Catheter for RF ablation having cooled electrode with electrically insulated sleeve |
| US5531685A (en) | 1993-06-11 | 1996-07-02 | Catheter Research, Inc. | Steerable variable stiffness device |
| FR2708860B1 (en) | 1993-08-11 | 1995-10-13 | Ela Medical Sa | Protection circuit for implantable electronic device. |
| US5558091A (en) | 1993-10-06 | 1996-09-24 | Biosense, Inc. | Magnetic determination of position and orientation |
| US5545193A (en) | 1993-10-15 | 1996-08-13 | Ep Technologies, Inc. | Helically wound radio-frequency emitting electrodes for creating lesions in body tissue |
| US5722400A (en) | 1995-02-16 | 1998-03-03 | Daig Corporation | Guiding introducers for use in the treatment of left ventricular tachycardia |
| US5454370A (en) | 1993-12-03 | 1995-10-03 | Avitall; Boaz | Mapping and ablation electrode configuration |
| US5921924A (en) | 1993-12-03 | 1999-07-13 | Avitall; Boaz | Mapping and ablation catheter system utilizing multiple control elements |
| US5928269A (en) | 1994-04-04 | 1999-07-27 | Alt; Eckhard | Apparatus and method for temporary atrial defibrillation with external defibrillator and implanted transvenous catheter and electrodes |
| US5617854A (en) | 1994-06-22 | 1997-04-08 | Munsif; Anand | Shaped catheter device and method |
| US5885278A (en) | 1994-10-07 | 1999-03-23 | E.P. Technologies, Inc. | Structures for deploying movable electrode elements |
| US6071274A (en) | 1996-12-19 | 2000-06-06 | Ep Technologies, Inc. | Loop structures for supporting multiple electrode elements |
| US5836947A (en) | 1994-10-07 | 1998-11-17 | Ep Technologies, Inc. | Flexible structures having movable splines for supporting electrode elements |
| US5722402A (en) | 1994-10-11 | 1998-03-03 | Ep Technologies, Inc. | Systems and methods for guiding movable electrode elements within multiple-electrode structures |
| US5876336A (en) | 1994-10-11 | 1999-03-02 | Ep Technologies, Inc. | Systems and methods for guiding movable electrode elements within multiple-electrode structure |
| US5624430A (en) | 1994-11-28 | 1997-04-29 | Eton; Darwin | Magnetic device to assist transcorporeal guidewire placement |
| US5647871A (en) | 1995-03-10 | 1997-07-15 | Microsurge, Inc. | Electrosurgery with cooled electrodes |
| US5810762A (en) | 1995-04-10 | 1998-09-22 | Genetronics, Inc. | Electroporation system with voltage control feedback for clinical applications |
| US20060024359A1 (en) | 1995-06-07 | 2006-02-02 | Walker Jeffrey P | Drug delivery system and method |
| US6090104A (en) | 1995-06-07 | 2000-07-18 | Cordis Webster, Inc. | Catheter with a spirally wound flat ribbon electrode |
| US5702438A (en) | 1995-06-08 | 1997-12-30 | Avitall; Boaz | Expandable recording and ablation catheter system |
| US5788692A (en) | 1995-06-30 | 1998-08-04 | Fidus Medical Technology Corporation | Mapping ablation catheter |
| US6023638A (en) | 1995-07-28 | 2000-02-08 | Scimed Life Systems, Inc. | System and method for conducting electrophysiological testing using high-voltage energy pulses to stun tissue |
| US5706823A (en) | 1995-08-18 | 1998-01-13 | Quinton Instrument Company | Electrophysiology filtering system |
| JP3333520B2 (en) | 1995-10-06 | 2002-10-15 | コーディス ウェブスター,インコーポレイティド | Split tip electrode catheter |
| DE29519651U1 (en) | 1995-12-14 | 1996-02-01 | Muntermann, Axel, 35583 Wetzlar | Device for linear radio frequency catheter ablation of endomyocardial tissue |
| BR9612395A (en) | 1995-12-29 | 1999-07-13 | Gyrus Medical Ltd | Electrosurgical instrument and an electrosurgical electrode set |
| US7141049B2 (en) | 1999-03-09 | 2006-11-28 | Thermage, Inc. | Handpiece for treatment of tissue |
| US5868736A (en) | 1996-04-12 | 1999-02-09 | Ep Technologies, Inc. | Systems and methods to control tissue heating or ablation with porous electrode structures |
| WO1997025917A1 (en) | 1996-01-19 | 1997-07-24 | Ep Technologies, Inc. | Multi-function electrode structures for electrically analyzing and heating body tissue |
| US5800482A (en) | 1996-03-06 | 1998-09-01 | Cardiac Pathways Corporation | Apparatus and method for linear lesion ablation |
| US5830224A (en) | 1996-03-15 | 1998-11-03 | Beth Israel Deaconess Medical Center | Catheter apparatus and methodology for generating a fistula on-demand between closely associated blood vessels at a pre-chosen anatomic site in-vivo |
| US5779699A (en) | 1996-03-29 | 1998-07-14 | Medtronic, Inc. | Slip resistant field focusing ablation catheter electrode |
| US5836942A (en) | 1996-04-04 | 1998-11-17 | Minnesota Mining And Manufacturing Company | Biomedical electrode with lossy dielectric properties |
| US5904709A (en) | 1996-04-17 | 1999-05-18 | The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration | Microwave treatment for cardiac arrhythmias |
| US5672170A (en) | 1996-06-20 | 1997-09-30 | Cynosure, Inc. | Laser transmyocardial revascularization arrangement |
| US6006131A (en) | 1996-08-13 | 1999-12-21 | Uab Research Foundation | Dual current pathway atrial defibrillation apparatus |
| DE59610941D1 (en) | 1996-09-27 | 2004-04-22 | Sulzer Osypka Gmbh | Device for performing diagnostic and / or therapeutic cardiac interventions with a catheter |
| US6464697B1 (en) | 1998-02-19 | 2002-10-15 | Curon Medical, Inc. | Stomach and adjoining tissue regions in the esophagus |
| US6311692B1 (en) | 1996-10-22 | 2001-11-06 | Epicor, Inc. | Apparatus and method for diagnosis and therapy of electrophysiological disease |
| US7052493B2 (en) | 1996-10-22 | 2006-05-30 | Epicor Medical, Inc. | Methods and devices for ablation |
| US6096036A (en) | 1998-05-05 | 2000-08-01 | Cardiac Pacemakers, Inc. | Steerable catheter with preformed distal shape and method for use |
| US6035238A (en) | 1997-08-13 | 2000-03-07 | Surx, Inc. | Noninvasive devices, methods, and systems for shrinking of tissues |
| US6002955A (en) | 1996-11-08 | 1999-12-14 | Medtronic, Inc. | Stabilized electrophysiology catheter and method for use |
| US6076012A (en) | 1996-12-19 | 2000-06-13 | Ep Technologies, Inc. | Structures for supporting porous electrode elements |
| US5916213A (en) | 1997-02-04 | 1999-06-29 | Medtronic, Inc. | Systems and methods for tissue mapping and ablation |
| US6039757A (en) | 1997-03-12 | 2000-03-21 | Cardiosynopsis, Inc. | In situ formed fenestrated stent |
| US6223085B1 (en) | 1997-05-06 | 2001-04-24 | Urologix, Inc. | Device and method for preventing restenosis |
| US6012457A (en) | 1997-07-08 | 2000-01-11 | The Regents Of The University Of California | Device and method for forming a circumferential conduction block in a pulmonary vein |
| US5849028A (en) | 1997-05-16 | 1998-12-15 | Irvine Biomedical, Inc. | Catheter and method for radiofrequency ablation of cardiac tissue |
| US5978704A (en) | 1997-06-03 | 1999-11-02 | Uab Research Foundation | Method and apparatus for treating cardiac arrhythmia |
| US5938660A (en) | 1997-06-27 | 1999-08-17 | Daig Corporation | Process and device for the treatment of atrial arrhythmia |
| US6164283A (en) | 1997-07-08 | 2000-12-26 | The Regents Of The University Of California | Device and method for forming a circumferential conduction block in a pulmonary vein |
| US6245064B1 (en) | 1997-07-08 | 2001-06-12 | Atrionix, Inc. | Circumferential ablation device assembly |
| US6966908B2 (en) | 1997-07-08 | 2005-11-22 | Atrionix, Inc. | Tissue ablation device assembly and method for electrically isolating a pulmonary vein ostium from an atrial wall |
| ATE433306T1 (en) | 1997-07-08 | 2009-06-15 | Univ California | DEVICE FOR CIRCUMFERENTIAL ABLATION |
| US6009351A (en) | 1997-07-14 | 1999-12-28 | Urologix, Inc. | System and method for transurethral heating with rectal cooling |
| US6014579A (en) | 1997-07-21 | 2000-01-11 | Cardiac Pathways Corp. | Endocardial mapping catheter with movable electrode |
| WO1999004851A1 (en) | 1997-07-22 | 1999-02-04 | Emed Corporation | Iontophoretic delivery of an agent into cardiac tissue |
| US6216034B1 (en) * | 1997-08-01 | 2001-04-10 | Genetronics, Inc. | Method of programming an array of needle electrodes for electroporation therapy of tissue |
| US6200312B1 (en) * | 1997-09-11 | 2001-03-13 | Vnus Medical Technologies, Inc. | Expandable vein ligator catheter having multiple electrode leads |
| US5895404A (en) | 1997-09-29 | 1999-04-20 | Ruiz; Carlos E. | Apparatus and methods for percutaneously forming a passageway between adjacent vessels or portions of a vessel |
| US6464699B1 (en) | 1997-10-10 | 2002-10-15 | Scimed Life Systems, Inc. | Method and apparatus for positioning a diagnostic or therapeutic element on body tissue and mask element for use with same |
| US6071281A (en) | 1998-05-05 | 2000-06-06 | Ep Technologies, Inc. | Surgical method and apparatus for positioning a diagnostic or therapeutic element within the body and remote power control unit for use with same |
| US6645200B1 (en) | 1997-10-10 | 2003-11-11 | Scimed Life Systems, Inc. | Method and apparatus for positioning a diagnostic or therapeutic element within the body and tip electrode for use with same |
| JP2001521774A (en) | 1997-10-31 | 2001-11-13 | シー・アール・バード・インコーポレーテッド | Ring-shaped electrode structure for diagnostic and ablation catheters |
| US6120500A (en) | 1997-11-12 | 2000-09-19 | Daig Corporation | Rail catheter ablation and mapping system |
| US5928270A (en) | 1997-12-02 | 1999-07-27 | Cardiocommand, Inc. | Method and apparatus for incremental cardioversion or defibrillation |
| US6517534B1 (en) | 1998-02-11 | 2003-02-11 | Cosman Company, Inc. | Peri-urethral ablation |
| DE19805530C1 (en) * | 1998-02-11 | 1999-07-22 | Marquette Hellige Gmbh | Device for improving signals in an electrocardiogram (ECG) subject to frequent artefacts |
| US6447505B2 (en) | 1998-02-11 | 2002-09-10 | Cosman Company, Inc. | Balloon catheter method for intra-urethral radio-frequency urethral enlargement |
| US20020095175A1 (en) | 1998-02-24 | 2002-07-18 | Brock David L. | Flexible instrument |
| US6167291A (en) | 1998-03-12 | 2000-12-26 | Cardima, Inc. | Protected pin connector for an electrophysiology catheter |
| DE19817553A1 (en) | 1998-04-15 | 1999-10-21 | Biotronik Mess & Therapieg | Ablation arrangement |
| US6030384A (en) | 1998-05-01 | 2000-02-29 | Nezhat; Camran | Bipolar surgical instruments having focused electrical fields |
| US6045550A (en) | 1998-05-05 | 2000-04-04 | Cardiac Peacemakers, Inc. | Electrode having non-joined thermocouple for providing multiple temperature-sensitive junctions |
| US6171305B1 (en) * | 1998-05-05 | 2001-01-09 | Cardiac Pacemakers, Inc. | RF ablation apparatus and method having high output impedance drivers |
| US6146381A (en) | 1998-05-05 | 2000-11-14 | Cardiac Pacemakers, Inc. | Catheter having distal region for deflecting axial forces |
| US6592581B2 (en) | 1998-05-05 | 2003-07-15 | Cardiac Pacemakers, Inc. | Preformed steerable catheter with movable outer sleeve and method for use |
| US6527767B2 (en) | 1998-05-20 | 2003-03-04 | New England Medical Center | Cardiac ablation system and method for treatment of cardiac arrhythmias and transmyocardial revascularization |
| US6231518B1 (en) | 1998-05-26 | 2001-05-15 | Comedicus Incorporated | Intrapericardial electrophysiological procedures |
| US6287306B1 (en) | 1998-06-22 | 2001-09-11 | Daig Corporation | Even temperature linear lesion ablation catheter |
| US6251107B1 (en) | 1998-06-25 | 2001-06-26 | Cardima, Inc. | Ep catheter |
| US6322559B1 (en) | 1998-07-06 | 2001-11-27 | Vnus Medical Technologies, Inc. | Electrode catheter having coil structure |
| US6623480B1 (en) | 1998-07-24 | 2003-09-23 | University Of Kentucky Research Foundation | Flexible recording/high energy electrode catheter with anchor for ablation of atrial flutter by radio frequency energy |
| US7435247B2 (en) | 1998-08-11 | 2008-10-14 | Arthrocare Corporation | Systems and methods for electrosurgical tissue treatment |
| US6251128B1 (en) | 1998-09-01 | 2001-06-26 | Fidus Medical Technology Corporation | Microwave ablation catheter with loop configuration |
| US8308719B2 (en) | 1998-09-21 | 2012-11-13 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Apparatus and method for ablating tissue |
| US6807447B2 (en) | 1998-09-25 | 2004-10-19 | Ep Medsystems, Inc. | Triple array defibrillation catheter and method of using the same |
| US6033403A (en) | 1998-10-08 | 2000-03-07 | Irvine Biomedical, Inc. | Long electrode catheter system and methods thereof |
| US6638278B2 (en) | 1998-11-23 | 2003-10-28 | C. R. Bard, Inc. | Intracardiac grasp catheter |
| IT1302900B1 (en) | 1998-12-04 | 2000-10-10 | Riccardo Fenici | AMAGNETIC CATHETER FOR THE SINGLE-CATHETER REGISTRATION OF MULTIPLE SINGLE-PHASE ACTION POTENTIALS, LOCABLE THREE-DIMENSIONALLY AND |
| US20070066972A1 (en) | 2001-11-29 | 2007-03-22 | Medwaves, Inc. | Ablation catheter apparatus with one or more electrodes |
| US6219582B1 (en) | 1998-12-30 | 2001-04-17 | Daig Corporation | Temporary atrial cardioversion catheter |
| US6206831B1 (en) | 1999-01-06 | 2001-03-27 | Scimed Life Systems, Inc. | Ultrasound-guided ablation catheter and methods of use |
| US20010007070A1 (en) | 1999-04-05 | 2001-07-05 | Medtronic, Inc. | Ablation catheter assembly and method for isolating a pulmonary vein |
| US6325797B1 (en) | 1999-04-05 | 2001-12-04 | Medtronic, Inc. | Ablation catheter and method for isolating a pulmonary vein |
| US6702811B2 (en) | 1999-04-05 | 2004-03-09 | Medtronic, Inc. | Ablation catheter assembly with radially decreasing helix and method of use |
| US6270476B1 (en) | 1999-04-23 | 2001-08-07 | Cryocath Technologies, Inc. | Catheter |
| US6272384B1 (en) | 1999-05-27 | 2001-08-07 | Urologix, Inc. | Microwave therapy apparatus |
| US7171263B2 (en) | 1999-06-04 | 2007-01-30 | Impulse Dynamics Nv | Drug delivery device |
| US6391024B1 (en) | 1999-06-17 | 2002-05-21 | Cardiac Pacemakers, Inc. | RF ablation apparatus and method having electrode/tissue contact assessment scheme and electrocardiogram filtering |
| US6300108B1 (en) | 1999-07-21 | 2001-10-09 | The Regents Of The University Of California | Controlled electroporation and mass transfer across cell membranes |
| DE19938558A1 (en) | 1999-08-17 | 2001-02-22 | Axel Muntermann | Catheters with improved electrical properties and treatment methods for improving the electrical properties of catheters |
| US6607520B2 (en) | 1999-09-15 | 2003-08-19 | The General Hospital Corporation | Coiled ablation catheter system |
| US6370412B1 (en) | 1999-10-07 | 2002-04-09 | Massachusetts Institute Of Technology | Method and apparatus for guiding ablative therapy of abnormal biological electrical excitation |
| US6613062B1 (en) | 1999-10-29 | 2003-09-02 | Medtronic, Inc. | Method and apparatus for providing intra-pericardial access |
| US6529756B1 (en) | 1999-11-22 | 2003-03-04 | Scimed Life Systems, Inc. | Apparatus for mapping and coagulating soft tissue in or around body orifices |
| US6892091B1 (en) | 2000-02-18 | 2005-05-10 | Biosense, Inc. | Catheter, method and apparatus for generating an electrical map of a chamber of the heart |
| DE10008918A1 (en) | 2000-02-25 | 2001-08-30 | Biotronik Mess & Therapieg | Ablation catheter to create linear lesions in cardiac muscle tissue |
| WO2001072368A2 (en) | 2000-03-31 | 2001-10-04 | Medtronic, Inc. | Intralumenal visualization system with deflectable mechanism |
| US7497844B2 (en) | 2000-03-31 | 2009-03-03 | Medtronic, Inc. | System and method for positioning implantable medical devices within coronary veins |
| US6652517B1 (en) | 2000-04-25 | 2003-11-25 | Uab Research Foundation | Ablation catheter, system, and method of use thereof |
| US6932811B2 (en) | 2000-04-27 | 2005-08-23 | Atricure, Inc. | Transmural ablation device with integral EKG sensor |
| US6546935B2 (en) | 2000-04-27 | 2003-04-15 | Atricure, Inc. | Method for transmural ablation |
| US20020107514A1 (en) | 2000-04-27 | 2002-08-08 | Hooven Michael D. | Transmural ablation device with parallel jaws |
| US6743239B1 (en) | 2000-05-25 | 2004-06-01 | St. Jude Medical, Inc. | Devices with a bendable tip for medical procedures |
| JP2004520865A (en) | 2000-07-25 | 2004-07-15 | リタ メディカル システムズ インコーポレイテッド | Apparatus for tumor detection and treatment using localized impedance measurements |
| US8251986B2 (en) | 2000-08-17 | 2012-08-28 | Angiodynamics, Inc. | Method of destroying tissue cells by eletroporation |
| US6728563B2 (en) | 2000-11-29 | 2004-04-27 | St. Jude Medical, Daig Division, Inc. | Electrophysiology/ablation catheter having “halo” configuration |
| US7081114B2 (en) | 2000-11-29 | 2006-07-25 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Electrophysiology/ablation catheter having lariat configuration of variable radius |
| AU2002248196A1 (en) | 2000-12-15 | 2002-08-12 | Tony R. Brown | Atrial fibrillation rf treatment device and method |
| US6620157B1 (en) | 2000-12-28 | 2003-09-16 | Senorx, Inc. | High frequency power source |
| DE10102089C1 (en) | 2001-01-18 | 2002-07-25 | Wolf Gmbh Richard | Surgical instrument |
| DE10102254A1 (en) | 2001-01-19 | 2002-08-08 | Celon Ag Medical Instruments | Device for the electrothermal treatment of the human or animal body |
| US6743226B2 (en) | 2001-02-09 | 2004-06-01 | Cosman Company, Inc. | Adjustable trans-urethral radio-frequency ablation |
| US7229402B2 (en) | 2001-02-09 | 2007-06-12 | Cardiac Output Technologies, Inc. | Minimally invasive ventricular assist technology and method |
| US7137975B2 (en) | 2001-02-13 | 2006-11-21 | Aciont, Inc. | Method for increasing the battery life of an alternating current iontophoresis device using a barrier-modifying agent |
| US6666863B2 (en) | 2001-03-01 | 2003-12-23 | Scimed Life Systems, Inc. | Device and method for percutaneous myocardial revascularization |
| US6666862B2 (en) | 2001-03-01 | 2003-12-23 | Cardiac Pacemakers, Inc. | Radio frequency ablation system and method linking energy delivery with fluid flow |
| US6743225B2 (en) | 2001-03-27 | 2004-06-01 | Uab Research Foundation | Electrophysiologic measure of endpoints for ablation lesions created in fibrillating substrates |
| US6619291B2 (en) | 2001-04-24 | 2003-09-16 | Edwin J. Hlavka | Method and apparatus for catheter-based annuloplasty |
| WO2002087676A2 (en) | 2001-04-27 | 2002-11-07 | C.R. Bard, Inc. | Electrophysiology catheter for mapping and/or ablation |
| US6972016B2 (en) | 2001-05-01 | 2005-12-06 | Cardima, Inc. | Helically shaped electrophysiology catheter |
| US6771996B2 (en) | 2001-05-24 | 2004-08-03 | Cardiac Pacemakers, Inc. | Ablation and high-resolution mapping catheter system for pulmonary vein foci elimination |
| US6685702B2 (en) | 2001-07-06 | 2004-02-03 | Rodolfo C. Quijano | Device for treating tissue and methods thereof |
| US20030018374A1 (en) | 2001-07-16 | 2003-01-23 | Paulos Lonnie E. | Treatment probe using RF energy |
| US6994706B2 (en) | 2001-08-13 | 2006-02-07 | Minnesota Medical Physics, Llc | Apparatus and method for treatment of benign prostatic hyperplasia |
| US8623012B2 (en) | 2001-08-15 | 2014-01-07 | Nuortho Surgical, Inc. | Electrosurgical plenum |
| JP2005532832A (en) | 2001-09-24 | 2005-11-04 | ノヴォスト コーポレイション | Method and apparatus using ionizing radiation for the treatment of arrhythmias |
| US7285116B2 (en) | 2004-05-15 | 2007-10-23 | Irvine Biomedical Inc. | Non-contact tissue ablation device and methods thereof |
| US8175680B2 (en) | 2001-11-09 | 2012-05-08 | Boston Scientific Scimed, Inc. | Systems and methods for guiding catheters using registered images |
| US6669693B2 (en) | 2001-11-13 | 2003-12-30 | Mayo Foundation For Medical Education And Research | Tissue ablation device and methods of using |
| US7542807B2 (en) | 2001-12-04 | 2009-06-02 | Endoscopic Technologies, Inc. | Conduction block verification probe and method of use |
| US6740084B2 (en) | 2001-12-18 | 2004-05-25 | Ethicon, Inc. | Method and device to enhance RF electrode performance |
| EP1465555B1 (en) | 2001-12-21 | 2015-05-06 | QuickRing Medical Technologies Ltd. | Implantation system for annuloplasty rings |
| US7493156B2 (en) | 2002-01-07 | 2009-02-17 | Cardiac Pacemakers, Inc. | Steerable guide catheter with pre-shaped rotatable shaft |
| US8062251B2 (en) | 2002-02-01 | 2011-11-22 | Vascular Designs, Inc. | Multi-function catheter and use thereof |
| US6926714B1 (en) | 2002-02-05 | 2005-08-09 | Jasbir S. Sra | Method for pulmonary vein isolation and catheter ablation of other structures in the left atrium in atrial fibrillation |
| US6932816B2 (en) | 2002-02-19 | 2005-08-23 | Boston Scientific Scimed, Inc. | Apparatus for converting a clamp into an electrophysiology device |
| US6733499B2 (en) | 2002-02-28 | 2004-05-11 | Biosense Webster, Inc. | Catheter having circular ablation assembly |
| US6869414B2 (en) | 2002-03-22 | 2005-03-22 | Cardiac Pacemakers, Inc. | Pre-shaped catheter with proximal articulation and pre-formed distal end |
| US8347891B2 (en) | 2002-04-08 | 2013-01-08 | Medtronic Ardian Luxembourg S.A.R.L. | Methods and apparatus for performing a non-continuous circumferential treatment of a body lumen |
| US7756583B2 (en) | 2002-04-08 | 2010-07-13 | Ardian, Inc. | Methods and apparatus for intravascularly-induced neuromodulation |
| US7617005B2 (en) | 2002-04-08 | 2009-11-10 | Ardian, Inc. | Methods and apparatus for thermally-induced renal neuromodulation |
| US7653438B2 (en) | 2002-04-08 | 2010-01-26 | Ardian, Inc. | Methods and apparatus for renal neuromodulation |
| US8774913B2 (en) | 2002-04-08 | 2014-07-08 | Medtronic Ardian Luxembourg S.A.R.L. | Methods and apparatus for intravasculary-induced neuromodulation |
| US6764486B2 (en) | 2002-04-24 | 2004-07-20 | Biotronik Mess- und Therapieger{haeck over (a)}te GmbH & Co. Ingenieurbüro Berlin | Ablation device for cardiac tissue, especially for forming a circular lesion around a vessel orifice in the heart |
| DE10218427A1 (en) | 2002-04-24 | 2003-11-06 | Biotronik Mess & Therapieg | Ablation device for cardiac tissue, in particular for creating a circular lesion around a vascular mouth in the heart |
| US20030204161A1 (en) | 2002-04-25 | 2003-10-30 | Bozidar Ferek-Petric | Implantable electroporation therapy device and method for using same |
| US6780178B2 (en) | 2002-05-03 | 2004-08-24 | The Board Of Trustees Of The Leland Stanford Junior University | Method and apparatus for plasma-mediated thermo-electrical ablation |
| US8216219B2 (en) * | 2002-05-27 | 2012-07-10 | Celon Ag | Device for electrosurgically destroying body tissue |
| US20030229379A1 (en) | 2002-06-06 | 2003-12-11 | Maynard Ramsey | Method for cardioversion or defibrillation using electrical impulses at pacing strength |
| US7367974B2 (en) | 2004-09-20 | 2008-05-06 | Wisconsin Alumni Research Foundation | Electrode array for tissue ablation |
| US20040082859A1 (en) | 2002-07-01 | 2004-04-29 | Alan Schaer | Method and apparatus employing ultrasound energy to treat body sphincters |
| US7001383B2 (en) | 2002-10-21 | 2006-02-21 | Biosense, Inc. | Real-time monitoring and mapping of ablation lesion formation in the heart |
| US20040082947A1 (en) | 2002-10-25 | 2004-04-29 | The Regents Of The University Of Michigan | Ablation catheters |
| US9730100B2 (en) | 2002-10-28 | 2017-08-08 | MeshDynamics | Terse message networks |
| US9819747B2 (en) | 2008-11-24 | 2017-11-14 | MeshDynamics | Chirp networks |
| EP1562506B1 (en) | 2002-11-15 | 2009-05-13 | C.R.Bard, Inc. | Electrophysiology catheter with ablation electrode |
| WO2004045672A2 (en) | 2002-11-15 | 2004-06-03 | The Government Of The United States As Represented By The Secretary Of The Department Of Health And Human Services | Variable curve catheter |
| US7195628B2 (en) | 2002-12-11 | 2007-03-27 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Atrial fibrillation therapy with pulmonary vein support |
| EP1585574A4 (en) | 2002-12-20 | 2006-04-26 | Cardiac Inv S Unltd Inc | Apparatus and method for implanting left ventricular pacing leads within the coronary sinus |
| US6984232B2 (en) | 2003-01-17 | 2006-01-10 | St. Jude Medical, Daig Division, Inc. | Ablation catheter assembly having a virtual electrode comprising portholes |
| US8192425B2 (en) | 2006-09-29 | 2012-06-05 | Baylis Medical Company Inc. | Radiofrequency perforation apparatus |
| US6960207B2 (en) | 2003-01-21 | 2005-11-01 | St Jude Medical, Daig Division, Inc. | Ablation catheter having a virtual electrode comprising portholes and a porous conductor |
| US7387629B2 (en) | 2003-01-21 | 2008-06-17 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Catheter design that facilitates positioning at tissue to be diagnosed or treated |
| US7622172B2 (en) | 2003-02-19 | 2009-11-24 | Erick Keenan | Composite flexible and conductive catheter electrode |
| WO2004086994A1 (en) | 2003-03-28 | 2004-10-14 | C.R. Bard, Inc. | Method and apparatus for electrosurgical ablation |
| US6985776B2 (en) | 2003-04-25 | 2006-01-10 | Medtronic, Inc. | Method and apparatus for coronary sinus cannulation |
| US6980843B2 (en) | 2003-05-21 | 2005-12-27 | Stereotaxis, Inc. | Electrophysiology catheter |
| US7163537B2 (en) | 2003-06-02 | 2007-01-16 | Biosense Webster, Inc. | Enhanced ablation and mapping catheter and method for treating atrial fibrillation |
| US7044946B2 (en) | 2003-06-10 | 2006-05-16 | Cryocath Technologies Inc. | Surgical clamp having treatment elements |
| US7540853B2 (en) | 2003-06-30 | 2009-06-02 | Cardiac Pacemakers, Inc. | Method and apparatus for diverting blood flow during ablation procedures |
| US6973339B2 (en) | 2003-07-29 | 2005-12-06 | Biosense, Inc | Lasso for pulmonary vein mapping and ablation |
| US20060009755A1 (en) | 2003-09-04 | 2006-01-12 | Sra Jasbir S | Method and system for ablation of atrial fibrillation and other cardiac arrhythmias |
| US8147486B2 (en) | 2003-09-22 | 2012-04-03 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Medical device with flexible printed circuit |
| US7229437B2 (en) | 2003-09-22 | 2007-06-12 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Medical device having integral traces and formed electrodes |
| US7435248B2 (en) | 2003-09-26 | 2008-10-14 | Boston Scientific Scimed, Inc. | Medical probes for creating and diagnosing circumferential lesions within or around the ostium of a vessel |
| US7179256B2 (en) | 2003-10-24 | 2007-02-20 | Biosense Webster, Inc. | Catheter with ablation needle and mapping assembly |
| US7207989B2 (en) | 2003-10-27 | 2007-04-24 | Biosense Webster, Inc. | Method for ablating with needle electrode |
| FR2861997A1 (en) | 2003-11-06 | 2005-05-13 | Fred Zacouto | Cardiac muscle stimulation device e.g. defibrillator, for use during tachycardia treatment, has impulse generator that sends stimulation pulse without delay at end of refractory period |
| US7666203B2 (en) | 2003-11-06 | 2010-02-23 | Nmt Medical, Inc. | Transseptal puncture apparatus |
| WO2005053555A1 (en) | 2003-12-01 | 2005-06-16 | Biotronik Crm Patent Ag | Electrode catheter for the electrotherapy of cardiac tissue |
| US8048067B2 (en) | 2003-12-24 | 2011-11-01 | The Regents Of The University Of California | Tissue ablation with irreversible electroporation |
| US20050187545A1 (en) * | 2004-02-20 | 2005-08-25 | Hooven Michael D. | Magnetic catheter ablation device and method |
| WO2005087128A1 (en) | 2004-03-05 | 2005-09-22 | Hansen Medical, Inc. | Robotic catheter system |
| US20060100610A1 (en) | 2004-03-05 | 2006-05-11 | Wallace Daniel T | Methods using a robotic catheter system |
| US8548583B2 (en) | 2004-03-10 | 2013-10-01 | Impulse Dynamics Nv | Protein activity modification |
| US7282057B2 (en) | 2004-03-30 | 2007-10-16 | Wilson-Cook Medical, Inc. | Pediatric atresia magnets |
| US20050261672A1 (en) | 2004-05-18 | 2005-11-24 | Mark Deem | Systems and methods for selective denervation of heart dysrhythmias |
| US7250049B2 (en) | 2004-05-27 | 2007-07-31 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Ablation catheter with suspension system incorporating rigid and flexible components |
| EP1750607A2 (en) | 2004-06-02 | 2007-02-14 | Medtronic, Inc. | Loop ablation apparatus and method |
| US7527625B2 (en) | 2004-08-04 | 2009-05-05 | Olympus Corporation | Transparent electrode for the radiofrequency ablation of tissue |
| US7556627B2 (en) | 2004-09-13 | 2009-07-07 | Ethicon Endo-Surgery, Inc. | Mucosal ablation device |
| US7282049B2 (en) | 2004-10-08 | 2007-10-16 | Sherwood Services Ag | Electrosurgical system employing multiple electrodes and method thereof |
| US20060089637A1 (en) | 2004-10-14 | 2006-04-27 | Werneth Randell L | Ablation catheter |
| FR2877207B1 (en) | 2004-10-29 | 2007-02-23 | Jacques Hamou | DEVICE FOR RESECTING ORGANIC TISSUE USED IN PARTICULAR IN UROLOGY OR HYSTEROSCOPY |
| US8409191B2 (en) | 2004-11-04 | 2013-04-02 | Boston Scientific Scimed, Inc. | Preshaped ablation catheter for ablating pulmonary vein ostia within the heart |
| US7468062B2 (en) | 2004-11-24 | 2008-12-23 | Ablation Frontiers, Inc. | Atrial ablation catheter adapted for treatment of septal wall arrhythmogenic foci and method of use |
| US7429261B2 (en) | 2004-11-24 | 2008-09-30 | Ablation Frontiers, Inc. | Atrial ablation catheter and method of use |
| US7731715B2 (en) | 2004-12-10 | 2010-06-08 | Edwards Lifesciences Corporation | Ablative treatment of atrial fibrillation via the coronary sinus |
| US7869865B2 (en) | 2005-01-07 | 2011-01-11 | Biosense Webster, Inc. | Current-based position sensing |
| US20070225589A1 (en) | 2005-01-11 | 2007-09-27 | Viswanathan Raju R | Single catheter diagnosis, navigation and treatment of arrhythmias |
| RU2401067C2 (en) | 2005-01-31 | 2010-10-10 | Конинклейке Филипс Электроникс Н.В. | Catheter guide wire and guiding technique in electrophysiological examinations |
| US9821158B2 (en) | 2005-02-17 | 2017-11-21 | Metacure Limited | Non-immediate effects of therapy |
| EP1874211B1 (en) * | 2005-04-21 | 2017-05-31 | Boston Scientific Scimed, Inc. | Control devices for energy delivery |
| US7588567B2 (en) | 2005-04-22 | 2009-09-15 | Abl Technologies, Llc | Method and system of stopping energy delivery of an ablation procedure with a computer based device for increasing safety of ablation procedures |
| US7578816B2 (en) | 2005-04-22 | 2009-08-25 | Abl Technologies, Llc | Method and system of increasing safety of cardiac ablation procedures |
| US7512447B2 (en) | 2005-04-25 | 2009-03-31 | Medtronic, Inc. | Medical electrical electrodes with conductive polymer |
| US20060264752A1 (en) | 2005-04-27 | 2006-11-23 | The Regents Of The University Of California | Electroporation controlled with real time imaging |
| US8571635B2 (en) | 2005-04-28 | 2013-10-29 | Boston Scientific Scimed, Inc. | Automated activation/deactivation of imaging device based on tracked medical device position |
| US8932208B2 (en) | 2005-05-26 | 2015-01-13 | Maquet Cardiovascular Llc | Apparatus and methods for performing minimally-invasive surgical procedures |
| US20060270900A1 (en) | 2005-05-26 | 2006-11-30 | Chin Albert K | Apparatus and methods for performing ablation |
| US9861836B2 (en) | 2005-06-16 | 2018-01-09 | Biosense Webster, Inc. | Less invasive methods for ablation of fat pads |
| EP2759276A1 (en) | 2005-06-20 | 2014-07-30 | Medtronic Ablation Frontiers LLC | Ablation catheter |
| US20060293730A1 (en) | 2005-06-24 | 2006-12-28 | Boris Rubinsky | Methods and systems for treating restenosis sites using electroporation |
| US20070005053A1 (en) | 2005-06-30 | 2007-01-04 | Dando Jeremy D | Ablation catheter with contoured openings in insulated electrodes |
| EP1907042B1 (en) | 2005-07-06 | 2009-03-11 | Vascular Pathways Inc. | Intravenous catheter insertion device and method of use |
| US20070021744A1 (en) | 2005-07-07 | 2007-01-25 | Creighton Francis M Iv | Apparatus and method for performing ablation with imaging feedback |
| AU2006268238A1 (en) | 2005-07-11 | 2007-01-18 | Medtronic Ablation Frontiers Llc | Low power tissue ablation system |
| ITBO20050495A1 (en) | 2005-07-22 | 2007-01-23 | Fiab Spa | EXOGUE PIPELINE |
| US7681579B2 (en) | 2005-08-02 | 2010-03-23 | Biosense Webster, Inc. | Guided procedures for treating atrial fibrillation |
| US7416552B2 (en) | 2005-08-22 | 2008-08-26 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Multipolar, multi-lumen, virtual-electrode catheter with at least one surface electrode and method for ablation |
| US8657814B2 (en) | 2005-08-22 | 2014-02-25 | Medtronic Ablation Frontiers Llc | User interface for tissue ablation system |
| JP2009506873A (en) | 2005-09-07 | 2009-02-19 | ザ ファウンドリー, インコーポレイテッド | Apparatus and method for disrupting subcutaneous structures |
| US7623899B2 (en) | 2005-09-16 | 2009-11-24 | Biosense Webster, Inc. | Catheter with flexible pre-shaped tip section |
| WO2007063443A2 (en) | 2005-12-02 | 2007-06-07 | Koninklijke Philips Electronics, N.V. | Automating the ablation procedure to minimize the need for manual intervention |
| US8603084B2 (en) | 2005-12-06 | 2013-12-10 | St. Jude Medical, Atrial Fibrillation Division, Inc. | System and method for assessing the formation of a lesion in tissue |
| US8403925B2 (en) | 2006-12-06 | 2013-03-26 | St. Jude Medical, Atrial Fibrillation Division, Inc. | System and method for assessing lesions in tissue |
| US10362959B2 (en) | 2005-12-06 | 2019-07-30 | St. Jude Medical, Atrial Fibrillation Division, Inc. | System and method for assessing the proximity of an electrode to tissue in a body |
| US8406866B2 (en) | 2005-12-06 | 2013-03-26 | St. Jude Medical, Atrial Fibrillation Division, Inc. | System and method for assessing coupling between an electrode and tissue |
| US8449535B2 (en) | 2005-12-06 | 2013-05-28 | St. Jude Medical, Atrial Fibrillation Division, Inc. | System and method for assessing coupling between an electrode and tissue |
| US9492226B2 (en) | 2005-12-06 | 2016-11-15 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Graphical user interface for real-time RF lesion depth display |
| WO2007076045A2 (en) | 2005-12-24 | 2007-07-05 | Crossman Arthur W | Circumferential ablation guide wire system and related method of using the same |
| US7857809B2 (en) | 2005-12-30 | 2010-12-28 | Biosense Webster, Inc. | Injection molded irrigated tip electrode and catheter having the same |
| US7879029B2 (en) | 2005-12-30 | 2011-02-01 | Biosense Webster, Inc. | System and method for selectively energizing catheter electrodes |
| US20070167740A1 (en) | 2005-12-30 | 2007-07-19 | Grunewald Debby E | Magnetic stabilization of catheter location sensor |
| JP4855482B2 (en) | 2005-12-30 | 2012-01-18 | シー・アール・バード・インコーポレーテッド | Method and apparatus for exfoliating heart tissue |
| US20070156135A1 (en) | 2006-01-03 | 2007-07-05 | Boris Rubinsky | System and methods for treating atrial fibrillation using electroporation |
| US7513896B2 (en) | 2006-01-24 | 2009-04-07 | Covidien Ag | Dual synchro-resonant electrosurgical apparatus with bi-directional magnetic coupling |
| US7374567B2 (en) | 2006-01-25 | 2008-05-20 | Heuser Richard R | Catheter system for connecting adjacent blood vessels |
| US7918850B2 (en) | 2006-02-17 | 2011-04-05 | Biosense Wabster, Inc. | Lesion assessment by pacing |
| EP2007466A4 (en) | 2006-03-31 | 2012-01-18 | Automated Medical Instr Inc | System and method for advancing, orienting, and immobilizing on internal body tissue a catheter or other therapeutic device |
| US7615044B2 (en) | 2006-05-03 | 2009-11-10 | Greatbatch Ltd. | Deflectable sheath handle assembly and method therefor |
| WO2007134039A2 (en) | 2006-05-08 | 2007-11-22 | Medeikon Corporation | Interferometric characterization of ablated tissue |
| US20140276782A1 (en) | 2013-03-15 | 2014-09-18 | Larry D. Paskar | Catheter system |
| US7729752B2 (en) | 2006-06-13 | 2010-06-01 | Rhythmia Medical, Inc. | Non-contact cardiac mapping, including resolution map |
| US7515954B2 (en) | 2006-06-13 | 2009-04-07 | Rhythmia Medical, Inc. | Non-contact cardiac mapping, including moving catheter and multi-beat integration |
| US7783352B1 (en) | 2006-06-23 | 2010-08-24 | Pacesetter, Inc. | Optimizing anti-tachycardia pacing for terminating atrial fibrillation |
| US8920411B2 (en) | 2006-06-28 | 2014-12-30 | Kardium Inc. | Apparatus and method for intra-cardiac mapping and ablation |
| US9119633B2 (en) | 2006-06-28 | 2015-09-01 | Kardium Inc. | Apparatus and method for intra-cardiac mapping and ablation |
| US8328752B2 (en) | 2006-06-30 | 2012-12-11 | Cvdevices, Llc | Devices, systems, and methods for promotion of infarct healing and reinforcement of border zone |
| US8048072B2 (en) | 2006-07-12 | 2011-11-01 | Les Hospitaux Universitaires de Geneva | Medical device for tissue ablation |
| US20080033426A1 (en) | 2006-07-27 | 2008-02-07 | Machell Charles H | Catheter system and method of use thereof |
| US8273081B2 (en) | 2006-09-08 | 2012-09-25 | Stereotaxis, Inc. | Impedance-based cardiac therapy planning method with a remote surgical navigation system |
| CA2666529A1 (en) | 2006-10-13 | 2008-04-24 | Apnex Medical, Inc. | Obstructive sleep apnea treatment devices, systems and methods |
| AU2007231704B2 (en) | 2006-11-29 | 2011-02-24 | Cathrx Ltd | Heat treating a biological site in a patient's body |
| US20080132885A1 (en) | 2006-12-01 | 2008-06-05 | Boris Rubinsky | Methods for treating tissue sites using electroporation |
| US20080132884A1 (en) | 2006-12-01 | 2008-06-05 | Boris Rubinsky | Systems for treating tissue sites using electroporation |
| EP2097762A1 (en) | 2006-12-22 | 2009-09-09 | Philips Intellectual Property & Standards GmbH | Transmission line for use in magnetic resonance system |
| US8449537B2 (en) | 2006-12-29 | 2013-05-28 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Ablation catheter with thermally mediated catheter body for mitigating blood coagulation and creating larger lesion |
| US8226648B2 (en) | 2007-12-31 | 2012-07-24 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Pressure-sensitive flexible polymer bipolar electrode |
| US7883508B2 (en) | 2006-12-29 | 2011-02-08 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Contact-sensitive pressure-sensitive conductive composite electrode and method for ablation |
| US8108069B2 (en) | 2007-01-10 | 2012-01-31 | Hansen Medical, Inc. | Robotic catheter system and methods |
| US9924998B2 (en) | 2007-01-12 | 2018-03-27 | Atricure, Inc. | Ablation system, clamp and method of use |
| US20080200913A1 (en) | 2007-02-07 | 2008-08-21 | Viswanathan Raju R | Single Catheter Navigation for Diagnosis and Treatment of Arrhythmias |
| US7655004B2 (en) | 2007-02-15 | 2010-02-02 | Ethicon Endo-Surgery, Inc. | Electroporation ablation apparatus, system, and method |
| WO2008118737A1 (en) | 2007-03-22 | 2008-10-02 | University Of Virginia Patent Foundation | Electrode catheter for ablation purposes and related method thereof |
| US11058354B2 (en) | 2007-03-19 | 2021-07-13 | University Of Virginia Patent Foundation | Access needle with direct visualization and related methods |
| US9468396B2 (en) | 2007-03-19 | 2016-10-18 | University Of Virginia Patent Foundation | Systems and methods for determining location of an access needle in a subject |
| EP2136702B1 (en) | 2007-03-26 | 2015-07-01 | Boston Scientific Limited | High resolution electrophysiology catheter |
| US8597288B2 (en) | 2008-10-01 | 2013-12-03 | St. Jude Medical, Artial Fibrillation Division, Inc. | Vacuum-stabilized ablation system |
| WO2008147603A2 (en) | 2007-04-19 | 2008-12-04 | S.D.M.H.Pty. Ltd. | Devices and methods for thermal ablation of biological tissue using geometric ablation patterns |
| EP3391844A1 (en) | 2007-04-19 | 2018-10-24 | Miramar Labs, Inc. | Apparatus for reducing sweat production |
| US8588885B2 (en) | 2007-05-09 | 2013-11-19 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Bendable catheter arms having varied flexibility |
| US8224416B2 (en) | 2007-05-09 | 2012-07-17 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Basket catheter having multiple electrodes |
| US8641704B2 (en) | 2007-05-11 | 2014-02-04 | Medtronic Ablation Frontiers Llc | Ablation therapy system and method for treating continuous atrial fibrillation |
| US8100900B2 (en) | 2007-05-11 | 2012-01-24 | Board Of Trustees Of The Leland Stanford Junior University | System for delivering therapy |
| US8216221B2 (en) | 2007-05-21 | 2012-07-10 | Estech, Inc. | Cardiac ablation systems and methods |
| US7742810B2 (en) | 2007-05-23 | 2010-06-22 | Boston Scientific Neuromodulation Corporation | Short duration pre-pulsing to reduce stimulation-evoked side-effects |
| US10220187B2 (en) | 2010-06-16 | 2019-03-05 | St. Jude Medical, Llc | Ablation catheter having flexible tip with multiple flexible electrode segments |
| US8160690B2 (en) | 2007-06-14 | 2012-04-17 | Hansen Medical, Inc. | System and method for determining electrode-tissue contact based on amplitude modulation of sensed signal |
| US20090024084A1 (en) | 2007-07-16 | 2009-01-22 | Peritec Biosciences Ltd. | Multi-lumen catheter assembly and method of providing relative motion thereto |
| US20090076502A1 (en) | 2007-09-14 | 2009-03-19 | Lazure Technologies, Llc. | Prostate cancer ablation |
| US20090118726A1 (en) | 2007-10-05 | 2009-05-07 | Coaptus Medical Corporation | Systems and Methods for Transeptal Cardiac Procedures, Including Tissue Sealing Members Associated Methods |
| US8500697B2 (en) | 2007-10-19 | 2013-08-06 | Pressure Products Medical Supplies, Inc. | Transseptal guidewire |
| US20100241185A1 (en) | 2007-11-09 | 2010-09-23 | University Of Virginia Patent Foundation | Steerable epicardial pacing catheter system placed via the subxiphoid process |
| US8906011B2 (en) | 2007-11-16 | 2014-12-09 | Kardium Inc. | Medical device for use in bodily lumens, for example an atrium |
| US9717501B2 (en) | 2007-11-21 | 2017-08-01 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Methods and systems for occluding vessels during cardiac ablation including optional electroanatomical guidance |
| US9452288B2 (en) * | 2007-12-06 | 2016-09-27 | Boston Scientific Neuromodulation Corporation | Multimodal neurostimulation systems and methods |
| WO2009082710A1 (en) | 2007-12-21 | 2009-07-02 | Endometabolic Solutions, Inc. | Methods and devices for endoscopically creating an anastomosis |
| US8353907B2 (en) | 2007-12-21 | 2013-01-15 | Atricure, Inc. | Ablation device with internally cooled electrodes |
| US8562600B2 (en) | 2007-12-27 | 2013-10-22 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Integration of control software with a medical device and system |
| US9204927B2 (en) | 2009-05-13 | 2015-12-08 | St. Jude Medical, Atrial Fibrillation Division, Inc. | System and method for presenting information representative of lesion formation in tissue during an ablation procedure |
| EP2231002A1 (en) | 2008-01-09 | 2010-09-29 | Mayo Foundation for Medical Education and Research | Mapping and ablation catheter system |
| WO2009092059A2 (en) | 2008-01-16 | 2009-07-23 | Catheter Robotics, Inc. | Remotely controlled catheter insertion system |
| US8235988B2 (en) | 2008-01-24 | 2012-08-07 | Coherex Medical, Inc. | Systems and methods for reduction of atrial fibrillation |
| US8617145B2 (en) | 2008-01-25 | 2013-12-31 | Intrepid Medical, Inc. | Methods of treating a cardiac arrhythmia by thoracoscopic production of a Cox maze III lesion set |
| US20090228003A1 (en) | 2008-03-04 | 2009-09-10 | Prorhythm, Inc. | Tissue ablation device using radiofrequency and high intensity focused ultrasound |
| EP2252226B1 (en) | 2008-03-12 | 2017-11-15 | AFreeze GmbH | Ablation system |
| US20100004623A1 (en) | 2008-03-27 | 2010-01-07 | Angiodynamics, Inc. | Method for Treatment of Complications Associated with Arteriovenous Grafts and Fistulas Using Electroporation |
| US8538509B2 (en) | 2008-04-02 | 2013-09-17 | Rhythmia Medical, Inc. | Intracardiac tracking system |
| US11254926B2 (en) | 2008-04-29 | 2022-02-22 | Virginia Tech Intellectual Properties, Inc. | Devices and methods for high frequency electroporation |
| US8992517B2 (en) | 2008-04-29 | 2015-03-31 | Virginia Tech Intellectual Properties Inc. | Irreversible electroporation to treat aberrant cell masses |
| US10117707B2 (en) | 2008-04-29 | 2018-11-06 | Virginia Tech Intellectual Properties, Inc. | System and method for estimating tissue heating of a target ablation zone for electrical-energy based therapies |
| US9198733B2 (en) | 2008-04-29 | 2015-12-01 | Virginia Tech Intellectual Properties, Inc. | Treatment planning for electroporation-based therapies |
| US10702326B2 (en) | 2011-07-15 | 2020-07-07 | Virginia Tech Intellectual Properties, Inc. | Device and method for electroporation based treatment of stenosis of a tubular body part |
| US8926606B2 (en) | 2009-04-09 | 2015-01-06 | Virginia Tech Intellectual Properties, Inc. | Integration of very short electric pulses for minimally to noninvasive electroporation |
| US9867652B2 (en) | 2008-04-29 | 2018-01-16 | Virginia Tech Intellectual Properties, Inc. | Irreversible electroporation using tissue vasculature to treat aberrant cell masses or create tissue scaffolds |
| WO2009137800A2 (en) | 2008-05-09 | 2009-11-12 | Angiodynamics, Inc. | Electroporation device and method |
| US9474574B2 (en) | 2008-05-21 | 2016-10-25 | Atricure, Inc. | Stabilized ablation systems and methods |
| US20090306651A1 (en) | 2008-06-09 | 2009-12-10 | Clint Schneider | Catheter assembly with front-loaded tip |
| US8206385B2 (en) | 2008-06-09 | 2012-06-26 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Catheter assembly with front-loaded tip and multi-contact connector |
| US20100010484A1 (en) * | 2008-07-14 | 2010-01-14 | Primaeva Medical, Inc. | Devices and methods for percutaneous energy delivery |
| EP2317952A1 (en) | 2008-07-17 | 2011-05-11 | Maestroheart SA | Medical device for tissue ablation |
| US8585695B2 (en) | 2008-07-22 | 2013-11-19 | Hue-Teh Shih | Systems and methods for noncontact ablation |
| US8221411B2 (en) | 2008-07-28 | 2012-07-17 | Medtronic, Inc. | Systems and methods for cardiac tissue electroporation ablation |
| JP4545210B2 (en) | 2008-09-11 | 2010-09-15 | 日本ライフライン株式会社 | Defibrillation catheter |
| US20100100093A1 (en) * | 2008-09-16 | 2010-04-22 | Lazure Technologies, Llc. | System and method for controlled tissue heating for destruction of cancerous cells |
| US9119533B2 (en) | 2008-10-07 | 2015-09-01 | Mc10, Inc. | Systems, methods, and devices having stretchable integrated circuitry for sensing and delivering therapy |
| US8808281B2 (en) | 2008-10-21 | 2014-08-19 | Microcube, Llc | Microwave treatment devices and methods |
| US8137343B2 (en) | 2008-10-27 | 2012-03-20 | Rhythmia Medical, Inc. | Tracking system using field mapping |
| US9220924B2 (en) | 2008-10-30 | 2015-12-29 | Vytronus, Inc. | System and method for energy delivery to tissue while monitoring position, lesion depth, and wall motion |
| US8414508B2 (en) | 2008-10-30 | 2013-04-09 | Vytronus, Inc. | System and method for delivery of energy to tissue while compensating for collateral tissue |
| US9192789B2 (en) | 2008-10-30 | 2015-11-24 | Vytronus, Inc. | System and method for anatomical mapping of tissue and planning ablation paths therein |
| US9192769B2 (en) | 2008-10-31 | 2015-11-24 | Medtronic, Inc. | Shunt-current reduction techniques for an implantable therapy system |
| US9795442B2 (en) | 2008-11-11 | 2017-10-24 | Shifamed Holdings, Llc | Ablation catheters |
| US8475445B2 (en) | 2008-12-01 | 2013-07-02 | Daniel Soroff | Spectral analysis of intracardiac electrograms to predict identification of radiofrequency ablation sites |
| US8475450B2 (en) | 2008-12-30 | 2013-07-02 | Biosense Webster, Inc. | Dual-purpose lasso catheter with irrigation |
| US8361066B2 (en) | 2009-01-12 | 2013-01-29 | Ethicon Endo-Surgery, Inc. | Electrical ablation devices |
| US20100191232A1 (en) | 2009-01-27 | 2010-07-29 | Boveda Marco Medical Llc | Catheters and methods for performing electrophysiological interventions |
| US8231603B2 (en) | 2009-02-10 | 2012-07-31 | Angiodynamics, Inc. | Irreversible electroporation and tissue regeneration |
| WO2010093603A1 (en) | 2009-02-11 | 2010-08-19 | Boston Scientific Scimed, Inc. | Insulated ablation catheter devices and methods of use |
| WO2010091701A1 (en) | 2009-02-12 | 2010-08-19 | Umc Utrecht Holding B.V. | Ablation catheter and method for electrically isolating cardiac tissue |
| WO2010096347A1 (en) | 2009-02-20 | 2010-08-26 | Boston Scientific Scimed, Inc. | Asymmetric dual directional steerable catheter sheath |
| US8747297B2 (en) | 2009-03-02 | 2014-06-10 | Olympus Corporation | Endoscopic heart surgery method |
| WO2010117806A1 (en) | 2009-03-31 | 2010-10-14 | Angiodynamics, Inc. | System and method for estimating a treatment region for a medical treatment device and for interactively planning a treatment of a patient |
| US8632534B2 (en) | 2009-04-03 | 2014-01-21 | Angiodynamics, Inc. | Irreversible electroporation (IRE) for congestive obstructive pulmonary disease (COPD) |
| US11382681B2 (en) | 2009-04-09 | 2022-07-12 | Virginia Tech Intellectual Properties, Inc. | Device and methods for delivery of high frequency electrical pulses for non-thermal ablation |
| US11638603B2 (en) | 2009-04-09 | 2023-05-02 | Virginia Tech Intellectual Properties, Inc. | Selective modulation of intracellular effects of cells using pulsed electric fields |
| US8287532B2 (en) | 2009-04-13 | 2012-10-16 | Biosense Webster, Inc. | Epicardial mapping and ablation catheter |
| WO2010120847A1 (en) | 2009-04-14 | 2010-10-21 | Old Dominion University Research Foundation | System and method for applying plasma sparks to tissue |
| US9566107B2 (en) | 2009-04-22 | 2017-02-14 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Method and apparatus for radiofrequency ablation with increased depth and/or decreased volume of ablated tissue |
| CA2703347C (en) | 2009-05-08 | 2016-10-04 | Endosense Sa | Method and apparatus for controlling lesion size in catheter-based ablation treatment |
| US8571647B2 (en) | 2009-05-08 | 2013-10-29 | Rhythmia Medical, Inc. | Impedance based anatomy generation |
| US8103338B2 (en) | 2009-05-08 | 2012-01-24 | Rhythmia Medical, Inc. | Impedance based anatomy generation |
| US8430875B2 (en) | 2009-05-19 | 2013-04-30 | Estech, Inc. (Endoscopic Technologies, Inc.) | Magnetic navigation systems and methods |
| WO2010138919A2 (en) | 2009-05-28 | 2010-12-02 | Angiodynamics, Inc. | System and method for synchronizing energy delivery to the cardiac rhythm |
| WO2010144402A2 (en) | 2009-06-08 | 2010-12-16 | Surgivision, Inc. | Mri-guided surgical systems with preset scan planes |
| GB2472216A (en) | 2009-07-28 | 2011-02-02 | Gyrus Medical Ltd | Bipolar electrosurgical instrument with four electrodes |
| US20110028962A1 (en) | 2009-07-31 | 2011-02-03 | Randell Werneth | Adjustable pulmonary vein ablation catheter |
| US9216055B2 (en) | 2009-08-05 | 2015-12-22 | Scr Inc. | Systems, devices and methods for treating the heart with ablation |
| US9042969B2 (en) | 2009-08-12 | 2015-05-26 | Angel Medical Systems, Inc. | Heart rate correction system and methods for the detection of cardiac events |
| US20110054487A1 (en) | 2009-09-02 | 2011-03-03 | Circulite, Inc. | Coaxial transseptal guide-wire and needle assembly |
| US20150321021A1 (en) | 2009-09-03 | 2015-11-12 | The Johns Hopkins University | Method and device for treating cardiac arrhythmias |
| US9642534B2 (en) | 2009-09-11 | 2017-05-09 | University Of Virginia Patent Foundation | Systems and methods for determining location of an access needle in a subject |
| US20110098694A1 (en) | 2009-10-28 | 2011-04-28 | Ethicon Endo-Surgery, Inc. | Methods and instruments for treating cardiac tissue through a natural orifice |
| US9861438B2 (en) | 2009-12-11 | 2018-01-09 | Biosense Webster (Israel), Ltd. | Pre-formed curved ablation catheter |
| US8608735B2 (en) | 2009-12-30 | 2013-12-17 | Biosense Webster (Israel) Ltd. | Catheter with arcuate end section |
| US9005198B2 (en) | 2010-01-29 | 2015-04-14 | Ethicon Endo-Surgery, Inc. | Surgical instrument comprising an electrode |
| US20110190727A1 (en) | 2010-02-02 | 2011-08-04 | Boston Scientific Scimed, Inc. | Intervascular catheter, system and method |
| US8556891B2 (en) | 2010-03-03 | 2013-10-15 | Medtronic Ablation Frontiers Llc | Variable-output radiofrequency ablation power supply |
| US20120046570A1 (en) | 2010-03-08 | 2012-02-23 | Alpha Orthopaedics, Inc. | Methods and devices for real time monitoring of collagen content and for altering collagen status |
| WO2011127211A2 (en) | 2010-04-08 | 2011-10-13 | The Regents Of The University Of California | Methods, system and apparatus for the detection, diagnosis and treatment of biological rhythm disorders |
| CA2796347A1 (en) | 2010-04-13 | 2011-10-20 | Sentreheart, Inc. | Methods and devices for pericardial access |
| AU2011241103A1 (en) | 2010-04-13 | 2012-11-08 | Sentreheart, Inc. | Methods and devices for treating atrial fibrillation |
| US9943363B2 (en) | 2010-04-28 | 2018-04-17 | Biosense Webster, Inc. | Irrigated ablation catheter with improved fluid flow |
| US9510894B2 (en) | 2010-04-28 | 2016-12-06 | Biosense Webster (Israel) Ltd. | Irrigated ablation catheter having irrigation ports with reduced hydraulic resistance |
| EP4257065A3 (en) | 2010-05-05 | 2023-12-27 | ElectroPhysiology Frontiers S.p.A. | Anchored cardiac ablation catheter |
| US9924997B2 (en) | 2010-05-05 | 2018-03-27 | Ablacor Medical Corporation | Anchored ablation catheter |
| US9655677B2 (en) | 2010-05-12 | 2017-05-23 | Shifamed Holdings, Llc | Ablation catheters including a balloon and electrodes |
| RU2531439C2 (en) | 2010-06-08 | 2014-10-20 | Торэй Индастриз, Инк. | Catheter for measuring electrical potential |
| ITRM20100314A1 (en) | 2010-06-09 | 2011-12-10 | Luca Viviana De | CATHETER WITH REVERSIBLE STABILITY, FOR STABILIZATION DURING THE ABLATION TRANSCATETERE BY MEANS OF RADIO FREQUENCY. |
| JP5936610B2 (en) | 2010-06-28 | 2016-06-22 | コリブリ ハート バルブ エルエルシーColibri Heart Valve Llc | Device for intracavity delivery of an intravascular injection device |
| US20120029512A1 (en) | 2010-07-30 | 2012-02-02 | Willard Martin R | Balloon with surface electrodes and integral cooling for renal nerve ablation |
| WO2012013243A1 (en) | 2010-07-30 | 2012-02-02 | Umc Utrecht Holding B.V. | Generator, combination of a generator and a catheter, and method for providing an electrical pulse |
| JP2012050538A (en) | 2010-08-31 | 2012-03-15 | Terumo Corp | Ablation device |
| US9289606B2 (en) | 2010-09-02 | 2016-03-22 | St. Jude Medical, Atrial Fibrillation Division, Inc. | System for electroporation therapy |
| US20120078320A1 (en) * | 2010-09-29 | 2012-03-29 | Medtronic, Inc. | Prioritized programming of multi-electrode pacing leads |
| US20120089089A1 (en) | 2010-10-12 | 2012-04-12 | Ethicon Endo-Surgery, Inc. | Methods of magnetically guiding and axially aligning distal ends of surgical devices |
| CN202478392U (en) | 2010-10-20 | 2012-10-10 | 美敦力阿迪安卢森堡有限责任公司 | Associated system of catheter device |
| EP2613723B1 (en) | 2010-11-19 | 2017-10-25 | St. Jude Medical Atrial Fibrillation Division Inc. | Electrode catheter device with indifferent electrode for direct current tissue therapies |
| JP6046631B2 (en) | 2010-11-19 | 2016-12-21 | ボストン サイエンティフィック サイムド,インコーポレイテッドBoston Scientific Scimed,Inc. | Renal nerve detection and excision device |
| US20120158021A1 (en) | 2010-12-19 | 2012-06-21 | Mitralign, Inc. | Steerable guide catheter having preformed curved shape |
| WO2012088149A2 (en) | 2010-12-20 | 2012-06-28 | Virginia Tech Intellectual Properties, Inc. | High-frequency electroporation for cancer therapy |
| US9308041B2 (en) | 2010-12-22 | 2016-04-12 | Biosense Webster (Israel) Ltd. | Lasso catheter with rotating ultrasound transducer |
| DE102010064101B4 (en) | 2010-12-23 | 2017-02-23 | Siemens Healthcare Gmbh | Pair of endocardial and epicardial catheters and catheters |
| US20120303019A1 (en) | 2010-12-25 | 2012-11-29 | Xue Zhao | Kind of cardiac ablation catheter with guide-wire |
| US9149327B2 (en) | 2010-12-27 | 2015-10-06 | St. Jude Medical Luxembourg Holding S.À.R.L. | Prediction of atrial wall electrical reconnection based on contact force measured during RF ablation |
| EP3482708B1 (en) | 2010-12-27 | 2021-03-10 | St. Jude Medical International Holding S.à r.l. | Prediction of atrial wall electrical reconnection based on contact force measured duing rf ablation |
| US9572620B2 (en) | 2010-12-29 | 2017-02-21 | Kyungmoo Ryu | System and method for treating arrhythmias in the heart using information obtained from heart wall motion |
| US9044245B2 (en) | 2011-01-05 | 2015-06-02 | Medtronic Ablation Frontiers Llc | Multipolarity epicardial radiofrequency ablation |
| US9095262B2 (en) | 2011-01-05 | 2015-08-04 | Mehdi Razavi | Guided ablation devices, systems, and methods |
| US9002442B2 (en) | 2011-01-13 | 2015-04-07 | Rhythmia Medical, Inc. | Beat alignment and selection for cardiac mapping |
| CA2764494A1 (en) | 2011-01-21 | 2012-07-21 | Kardium Inc. | Enhanced medical device for use in bodily cavities, for example an atrium |
| US9480525B2 (en) | 2011-01-21 | 2016-11-01 | Kardium, Inc. | High-density electrode-based medical device system |
| US9314620B2 (en) | 2011-02-28 | 2016-04-19 | Ethicon Endo-Surgery, Inc. | Electrical ablation devices and methods |
| CA2842302C (en) | 2011-03-08 | 2019-09-10 | Todd J. Cohen | Ablation catheter system with safety features |
| US9937002B2 (en) | 2011-03-08 | 2018-04-10 | Nexus Control Systems, Llc | Ablation catheter system with safety features |
| CN103747756B (en) | 2011-04-13 | 2016-12-07 | 维特罗纳斯有限公司 | integrated ablation and mapping system |
| CN103718191B (en) | 2011-05-02 | 2018-02-02 | 加利福尼亚大学董事会 | Systems and methods for targeting cardiac rhythm disorders using shaping ablation |
| KR101248959B1 (en) | 2011-05-12 | 2013-04-01 | 신경민 | Electrode device having flexible tube for high frequency thermotherapy |
| US9072518B2 (en) | 2011-05-31 | 2015-07-07 | Atricure, Inc. | High-voltage pulse ablation systems and methods |
| US20120310230A1 (en) | 2011-06-01 | 2012-12-06 | Angiodynamics, Inc. | Coaxial dual function probe and method of use |
| US20120316557A1 (en) | 2011-06-08 | 2012-12-13 | Tyco Healthcare Group Lp | Septoplasty Instrument |
| EP2823857B1 (en) | 2011-06-15 | 2015-08-12 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. | Apparatus for terminating an atrial fibrillation of an atrium of a heart |
| US10506948B2 (en) | 2011-07-05 | 2019-12-17 | Cardioinsight Technologies, Inc. | Localization for electrocardiographic mapping |
| WO2013013099A1 (en) | 2011-07-19 | 2013-01-24 | Adagio Medical, Inc. | Methods and devices for the treatment of atrial fibrillation |
| US20130030430A1 (en) | 2011-07-29 | 2013-01-31 | Stewart Mark T | Intracardiac tools and methods for delivery of electroporation therapies |
| EP2765940B1 (en) | 2011-10-11 | 2015-08-26 | Boston Scientific Scimed, Inc. | Off-wall electrode device for nerve modulation |
| WO2013096199A1 (en) | 2011-12-20 | 2013-06-27 | Cardiac Pacemakers, Inc. | Ectopic-triggered para-his stimulation |
| US8825130B2 (en) | 2011-12-30 | 2014-09-02 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Electrode support structure assemblies |
| US9687289B2 (en) | 2012-01-04 | 2017-06-27 | Biosense Webster (Israel) Ltd. | Contact assessment based on phase measurement |
| JP2015506234A (en) | 2012-01-10 | 2015-03-02 | ボストン サイエンティフィック サイムド,インコーポレイテッドBoston Scientific Scimed,Inc. | Electrophysiology system |
| US9414881B2 (en) | 2012-02-08 | 2016-08-16 | Angiodynamics, Inc. | System and method for increasing a target zone for electrical ablation |
| US8808273B2 (en) | 2012-02-10 | 2014-08-19 | Biosense Webster (Israel) Ltd. | Electrophysiology catheter with mechanical use limiter |
| US9095350B2 (en) | 2012-05-01 | 2015-08-04 | Medtronic Ablation Frontiers Llc | Impedance detection of venous placement of multi-electrode catheters |
| WO2013165584A1 (en) | 2012-05-04 | 2013-11-07 | St. Jude Medical, Atrial Fibrillation Division, Inc. | System and method for controlling delivery of ablation energy to tissue |
| US9017321B2 (en) | 2012-05-21 | 2015-04-28 | Kardium, Inc. | Systems and methods for activating transducers |
| US9554847B2 (en) | 2012-07-02 | 2017-01-31 | Biosense Webster (Israel) Ltd. | Real time assessment of ablation from electrocardiogram signals |
| US9101374B1 (en) | 2012-08-07 | 2015-08-11 | David Harris Hoch | Method for guiding an ablation catheter based on real time intracardiac electrical signals and apparatus for performing the method |
| CA2881462C (en) | 2012-08-09 | 2020-07-14 | University Of Iowa Research Foundation | Catheters, catheter systems, and methods for puncturing through a tissue structure |
| US9277957B2 (en) | 2012-08-15 | 2016-03-08 | Ethicon Endo-Surgery, Inc. | Electrosurgical devices and methods |
| US20140052216A1 (en) | 2012-08-15 | 2014-02-20 | Ethicon Endo-Surgery, Inc. | Methods for promoting wound healing |
| US9801681B2 (en) | 2012-08-17 | 2017-10-31 | Medtronic Ablation Frontiers Llc | Catheters and methods for intracardiac electrical mapping |
| US9168004B2 (en) | 2012-08-20 | 2015-10-27 | Biosense Webster (Israel) Ltd. | Machine learning in determining catheter electrode contact |
| WO2014031800A1 (en) | 2012-08-22 | 2014-02-27 | Energize Medical Llc | Therapeutic energy systems |
| EP2890292B1 (en) | 2012-08-31 | 2021-01-13 | Acutus Medical, Inc. | Catheter system for the heart |
| JP2014054430A (en) | 2012-09-13 | 2014-03-27 | Nippon Koden Corp | Catheter |
| US11096741B2 (en) | 2012-10-10 | 2021-08-24 | Biosense Webster (Israel) Ltd. | Ablation power control based on contact force |
| US9827036B2 (en) | 2012-11-13 | 2017-11-28 | Pulnovo Medical (Wuxi) Co., Ltd. | Multi-pole synchronous pulmonary artery radiofrequency ablation catheter |
| US9757185B2 (en) | 2012-11-29 | 2017-09-12 | Gyrus Acmi, Inc. | Quadripolar forceps |
| WO2014089373A1 (en) | 2012-12-05 | 2014-06-12 | University Of Rochester | Catheter with integrated transeptal puncture needle |
| US9023036B2 (en) | 2012-12-07 | 2015-05-05 | Biosense Webster (Israel) Ltd. | Lasso catheter with tip electrode |
| US9078667B2 (en) | 2012-12-11 | 2015-07-14 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Catheter having reduced force concentration at tissue contact site |
| US9474850B2 (en) | 2012-12-11 | 2016-10-25 | Biosense Webster (Israel) Ltd. | Lasso catheter with guide wire |
| WO2014100579A1 (en) | 2012-12-21 | 2014-06-26 | David Anderson | Functional gain measurement technique and representation |
| US9204820B2 (en) | 2012-12-31 | 2015-12-08 | Biosense Webster (Israel) Ltd. | Catheter with combined position and pressure sensing structures |
| US10537286B2 (en) | 2013-01-08 | 2020-01-21 | Biosense Webster (Israel) Ltd. | Catheter with multiple spines of different lengths arranged in one or more distal assemblies |
| WO2014118734A2 (en) | 2013-01-31 | 2014-08-07 | David Prutchi | Unipolar and/or bipolar ablation catheter |
| US9031642B2 (en) | 2013-02-21 | 2015-05-12 | Medtronic, Inc. | Methods for simultaneous cardiac substrate mapping using spatial correlation maps between neighboring unipolar electrograms |
| US9474486B2 (en) | 2013-03-08 | 2016-10-25 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Basket for a multi-electrode array catheter |
| US9519021B2 (en) | 2013-03-11 | 2016-12-13 | Covidien Lp | Systems and methods for detecting abnormalities within a circuit of an electrosurgical generator |
| US9486272B2 (en) | 2013-03-12 | 2016-11-08 | Biosense Webster (Israel) Ltd. | Force feedback device and method for catheters |
| CN105142558A (en) | 2013-03-15 | 2015-12-09 | 美敦力阿迪安卢森堡有限公司 | Treatment device with electrode contact surface configured for enhancing uniformity of electrical energy distribution and associated devices and methods |
| US9345540B2 (en) | 2013-03-15 | 2016-05-24 | Medtronic Ablation Frontiers Llc | Contact specific RF therapy balloon |
| SG11201507936UA (en) | 2013-03-27 | 2015-10-29 | Autonomix Medical Inc | Neurological traffic and receptor evaluation and modification: systems and methods |
| KR20150140760A (en) | 2013-04-08 | 2015-12-16 | 아파마 메디칼, 인크. | Cardiac ablation catheters and methods of use thereof |
| US10575743B2 (en) | 2013-04-11 | 2020-03-03 | Biosense Webster (Israel) Ltd. | High electrode density basket catheter |
| US20160113709A1 (en) | 2013-06-05 | 2016-04-28 | Tel Hashomer Medical Research Infrastructure And Services Ltd | Myocardial ablation by irreversible electroporation |
| EP3030185B1 (en) | 2013-08-06 | 2023-05-10 | Memorial Sloan Kettering Cancer Center | System and computer-accessible medium for in-vivo tissue ablation and/or damage |
| JP6280652B2 (en) | 2013-08-29 | 2018-02-14 | ボストン サイエンティフィック ニューロモデュレイション コーポレイション | System and method for adjusting compliance voltage of neuromodulation device |
| US9931046B2 (en) | 2013-10-25 | 2018-04-03 | Ablative Solutions, Inc. | Intravascular catheter with peri-vascular nerve activity sensors |
| WO2015066322A1 (en) | 2013-11-01 | 2015-05-07 | Boston Scientific Scimed, Inc. | Cardiac mapping using latency interpolation |
| EP3071137A1 (en) | 2013-11-20 | 2016-09-28 | Boston Scientific Scimed, Inc. | Ablation medical devices and methods for making and using ablation medical devices |
| US20150173828A1 (en) | 2013-12-23 | 2015-06-25 | Boaz Avitall | Small loop ablation catheter |
| US20160324564A1 (en) | 2013-12-27 | 2016-11-10 | Empire Technology Development Llc | Devices and techniques for ablative treatment |
| EP3091921B1 (en) | 2014-01-06 | 2019-06-19 | Farapulse, Inc. | Apparatus for renal denervation ablation |
| EP3091925A1 (en) | 2014-01-06 | 2016-11-16 | Iowa Approach Inc. | Devices and methods for delivering therapeutic electrical impulses |
| US20170172654A1 (en) | 2014-02-11 | 2017-06-22 | St. Jude Medical, Cardiology Division, Inc. | Ablation catheter and associated methods |
| AU2015218223B2 (en) | 2014-02-17 | 2019-05-16 | Children's National Medical Center | Delivery tool and method for devices in the pericardial space |
| JP6393768B2 (en) | 2014-02-25 | 2018-09-19 | セント・ジュード・メディカル,カーディオロジー・ディヴィジョン,インコーポレイテッド | System and method for local electrophysiological representation of cardiac matrix characteristics using a multi-electrode catheter |
| GEP20197025B (en) | 2014-03-20 | 2019-10-10 | S P A Atricath | Ablation catheter and ablation apparatus |
| WO2015143327A1 (en) | 2014-03-21 | 2015-09-24 | Mayo Foundation For Medical Education And Research | Multi-electrode epicardial pacing |
| US9956035B2 (en) | 2014-03-27 | 2018-05-01 | Biosense Webster (Israel) Ltd. | Temperature measurement in catheter |
| US20150289923A1 (en) | 2014-04-14 | 2015-10-15 | Virginia Tech Intellectual Properties, Inc. | Treatment planning for electrical-energy based therapies based on cell characteristics |
| US10342606B2 (en) | 2014-05-06 | 2019-07-09 | Cosman Instruments, Llc | Electrosurgical generator |
| EP3495018B1 (en) * | 2014-05-07 | 2023-09-06 | Farapulse, Inc. | Apparatus for selective tissue ablation |
| WO2015175944A1 (en) | 2014-05-16 | 2015-11-19 | Gary Long | Methods and apparatus for multi-catheter tissue ablation |
| US9848795B2 (en) | 2014-06-04 | 2017-12-26 | Boston Scientific Scimed Inc. | Electrode assembly |
| WO2015192018A1 (en) | 2014-06-12 | 2015-12-17 | Iowa Approach Inc. | Method and apparatus for rapid and selective tissue ablation with cooling |
| EP3154463B1 (en) | 2014-06-12 | 2019-03-27 | Farapulse, Inc. | Apparatus for rapid and selective transurethral tissue ablation |
| US12114911B2 (en) | 2014-08-28 | 2024-10-15 | Angiodynamics, Inc. | System and method for ablating a tissue site by electroporation with real-time pulse monitoring |
| WO2016059027A1 (en) | 2014-10-13 | 2016-04-21 | Dr Philippe Debruyne Bvba | Limited ablation for the treatment of sick sinus syndrome and other inappropriate sinus bradycardias |
| JP2017529169A (en) | 2014-10-13 | 2017-10-05 | ボストン サイエンティフィック サイムド,インコーポレイテッドBoston Scientific Scimed,Inc. | Tissue diagnosis and treatment using mini-electrodes |
| EP3206613B1 (en) * | 2014-10-14 | 2019-07-03 | Farapulse, Inc. | Apparatus for rapid and safe pulmonary vein cardiac ablation |
| US10231778B2 (en) | 2014-10-20 | 2019-03-19 | Biosense Webster (Israel) Ltd. | Methods for contemporaneous assessment of renal denervation |
| WO2016065337A1 (en) | 2014-10-24 | 2016-04-28 | Boston Scientific Scimed Inc. | Medical devices with a flexible electrode assembly coupled to an ablation tip |
| JP6725178B2 (en) | 2014-11-19 | 2020-07-15 | エピックス セラピューティクス,インコーポレイテッド | Ablation apparatus, systems and methods using high resolution electrode assemblies |
| CA2969129A1 (en) | 2014-12-03 | 2016-06-09 | Metavention, Inc. | Systems and methods for modulating nerves or other tissue |
| US10271893B2 (en) | 2014-12-15 | 2019-04-30 | Medtronic Ablation Frontiers Llc | Timed energy delivery |
| US9743854B2 (en) | 2014-12-18 | 2017-08-29 | Boston Scientific Scimed, Inc. | Real-time morphology analysis for lesion assessment |
| JP2018501874A (en) | 2014-12-31 | 2018-01-25 | セント・ジュード・メディカル,カーディオロジー・ディヴィジョン,インコーポレイテッド | Filter circuit for electrophysiology system |
| US9782099B2 (en) | 2014-12-31 | 2017-10-10 | Biosense Webster (Israel) Ltd. | Basket catheter with improved spine flexibility |
| WO2016183337A2 (en) | 2015-05-12 | 2016-11-17 | National University Of Ireland Galway | Devices for therapeutic nasal neuromodulation and associated methods and systems |
| WO2016180934A1 (en) | 2015-05-12 | 2016-11-17 | Umc Utrecht Holding B.V. | Asymmetric balanced waveform for ac cardiac irreversible electroporation |
| WO2016201264A1 (en) | 2015-06-11 | 2016-12-15 | Massachusetts Institute Of Technology | Methods for inducing electroporation and tissue ablation |
| US9949656B2 (en) | 2015-06-29 | 2018-04-24 | Biosense Webster (Israel) Ltd. | Catheter with stacked spine electrode assembly |
| US10583294B2 (en) | 2015-07-02 | 2020-03-10 | Dirk De Ridder | Methods and apparatus for sensing cross-frequency coupling and neuromodulation |
| CN107921258B (en) | 2015-08-06 | 2021-09-07 | 美敦力公司 | Cardiac pulse field ablation |
| US9931487B2 (en) | 2015-08-06 | 2018-04-03 | Boston Scientific Scimed, Inc. | Bidirectional steering control apparatus for a catheter |
| US20170071543A1 (en) | 2015-09-14 | 2017-03-16 | Biosense Webster (Israel) Ltd. | Convertible basket catheter |
| CN108472481A (en) | 2015-10-06 | 2018-08-31 | 哈尔西恩医疗有限公司 | Aortorenal ganglions detects |
| US20170105793A1 (en) | 2015-10-15 | 2017-04-20 | Boston Scientific Scimed, Inc. | Energy delivery devices and related methods of use |
| JP6785301B2 (en) | 2015-11-04 | 2020-11-18 | ボストン サイエンティフィック サイムド,インコーポレイテッドBoston Scientific Scimed,Inc. | Medical devices and related methods |
| CA3006427A1 (en) | 2015-12-01 | 2017-06-08 | Symap Medical (Suzhou), Ltd | System and method for mapping functional nerves innervating wall of arteries,3-d mapping and catheters for same |
| US20170189097A1 (en) | 2016-01-05 | 2017-07-06 | Iowa Approach Inc. | Systems, apparatuses and methods for delivery of ablative energy to tissue |
| EP3399933B1 (en) | 2016-01-05 | 2021-09-01 | Farapulse, Inc. | Systems for delivery of pulsed electric field ablative energy to endocardial tissue |
| EP3399931B1 (en) | 2016-01-05 | 2022-04-06 | Farapulse, Inc. | System for delivery of ablative energy to tissue |
| US10130423B1 (en) | 2017-07-06 | 2018-11-20 | Farapulse, Inc. | Systems, devices, and methods for focal ablation |
| US10660702B2 (en) | 2016-01-05 | 2020-05-26 | Farapulse, Inc. | Systems, devices, and methods for focal ablation |
| US10172673B2 (en) | 2016-01-05 | 2019-01-08 | Farapulse, Inc. | Systems devices, and methods for delivery of pulsed electric field ablative energy to endocardial tissue |
| US10548665B2 (en) | 2016-02-29 | 2020-02-04 | Pulse Biosciences, Inc. | High-voltage analog circuit pulser with feedback control |
| US10874451B2 (en) | 2016-02-29 | 2020-12-29 | Pulse Biosciences, Inc. | High-voltage analog circuit pulser and pulse generator discharge circuit |
| WO2017192510A2 (en) | 2016-05-02 | 2017-11-09 | Affera, Inc. | Pulsed radiofrequency ablation |
| EP3471631A4 (en) | 2016-06-16 | 2020-03-04 | Farapulse, Inc. | GUIDE WIRE DISTRIBUTION SYSTEMS, APPARATUSES AND METHODS |
| WO2018005511A1 (en) | 2016-06-27 | 2018-01-04 | Gala Therapeutics, Inc. | Generator and a catheter with an electrode and a method for treating a lung passageway |
| AU2017357869B2 (en) | 2016-11-11 | 2023-06-15 | National University Of Ireland, Galway | Devices, systems, and methods for specializing, monitoring, and/or evaluating therapeutic nasal neuromodulation |
| EP3554406A1 (en) | 2016-12-19 | 2019-10-23 | Boston Scientific Scimed Inc. | Distally-facing electrode array with longitudinally mounted splines |
| US20180184982A1 (en) | 2017-01-05 | 2018-07-05 | Biosense Webster (Israel) Ltd. | Hybrid balloon basket catheter |
| US10912609B2 (en) | 2017-01-06 | 2021-02-09 | St. Jude Medical, Cardiology Division, Inc. | Pulmonary vein isolation balloon catheter |
| US11432871B2 (en) | 2017-04-10 | 2022-09-06 | St. Jude Medical, Cardiology Division, Inc. | Electroporation system and method of preconditioning tissue for electroporation therapy |
| CN110461262B (en) | 2017-04-10 | 2023-01-06 | 圣犹达医疗用品心脏病学部门有限公司 | Electroporation system and method of stimulating catheter |
| EP4005500A1 (en) | 2017-04-20 | 2022-06-01 | Medtronic, Inc. | Stabilization of a transseptal delivery device |
| US9987081B1 (en) | 2017-04-27 | 2018-06-05 | Iowa Approach, Inc. | Systems, devices, and methods for signal generation |
| US10617867B2 (en) | 2017-04-28 | 2020-04-14 | Farapulse, Inc. | Systems, devices, and methods for delivery of pulsed electric field ablative energy to esophageal tissue |
| EP3634284A1 (en) | 2017-06-06 | 2020-04-15 | Cardiac Pacemakers, Inc. | Ablation delivery using a catheter having a semi-permeable inflatable balloon structure |
| US20180360534A1 (en) | 2017-06-19 | 2018-12-20 | St. Jude Medical, Cardiology Division, Inc. | Apparatuses and methods for high-density sensing and ablation during a medical procedure |
| US11633121B2 (en) | 2017-08-04 | 2023-04-25 | Medtronic, Inc. | Ablation check pulse routine and integration for electroporation |
| US10850095B2 (en) | 2017-08-08 | 2020-12-01 | Pulse Biosciences, Inc. | Treatment of tissue by the application of energy |
| EP4279004B1 (en) | 2017-10-26 | 2025-08-13 | Boston Scientific Scimed, Inc. | Use of electromagnetic fields in ire device delivery and therapy monitoring |
| EP3723845B1 (en) | 2017-12-11 | 2025-01-22 | Mayo Foundation for Medical Education and Research | Systems for electroporation |
| JP7106644B2 (en) | 2017-12-19 | 2022-07-26 | セント・ジュード・メディカル,カーディオロジー・ディヴィジョン,インコーポレイテッド | A method for assessing contact between electrodes and tissue using complex impedance measurements |
| DK3731772T3 (en) | 2017-12-26 | 2024-06-03 | Galvanize Therapeutics Inc | SYSTEMS FOR THE TREATMENT OF DISEASE STATES AND DISORDERS |
| US20190336198A1 (en) | 2018-05-03 | 2019-11-07 | Farapulse, Inc. | Systems, devices, and methods for ablation using surgical clamps |
| WO2019217433A1 (en) | 2018-05-07 | 2019-11-14 | Farapulse, Inc. | Systems, apparatuses and methods for delivery of ablative energy to tissue |
| EP3578124A1 (en) | 2018-06-05 | 2019-12-11 | National University of Ireland Galway | Electrophysiology apparatus |
-
2015
- 2015-05-15 WO PCT/US2015/031086 patent/WO2015175944A1/en active Application Filing
- 2015-05-15 EP EP15726465.6A patent/EP3142584A1/en not_active Withdrawn
-
2016
- 2016-11-02 US US15/341,523 patent/US20170065340A1/en not_active Abandoned
-
2017
- 2017-10-26 US US15/795,075 patent/US20180042675A1/en not_active Abandoned
-
2021
- 2021-03-19 US US17/207,053 patent/US12137968B2/en active Active
-
2024
- 2024-11-11 US US18/943,623 patent/US20250064511A1/en active Pending
Patent Citations (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4200104A (en) * | 1977-11-17 | 1980-04-29 | Valleylab, Inc. | Contact area measurement apparatus for use in electrosurgery |
| US5242441A (en) * | 1992-02-24 | 1993-09-07 | Boaz Avitall | Deflectable catheter with rotatable tip electrode |
| US20040087939A1 (en) * | 1993-05-10 | 2004-05-06 | Arthrocare Corporation | Methods for electrosurgical tissue treatment between spaced apart electrodes |
| US5578040A (en) * | 1994-06-14 | 1996-11-26 | Smith; Albert C. | Ocular repair system and apparatus |
| US5836874A (en) * | 1996-04-08 | 1998-11-17 | Ep Technologies, Inc. | Multi-function electrode structures for electrically analyzing and heating body tissue |
| US5863291A (en) * | 1996-04-08 | 1999-01-26 | Cardima, Inc. | Linear ablation assembly |
| US6805128B1 (en) * | 1996-10-22 | 2004-10-19 | Epicor Medical, Inc. | Apparatus and method for ablating tissue |
| US20030130711A1 (en) * | 2001-09-28 | 2003-07-10 | Pearson Robert M. | Impedance controlled tissue ablation apparatus and method |
| US20060293731A1 (en) * | 2005-06-24 | 2006-12-28 | Boris Rubinsky | Methods and systems for treating tumors using electroporation |
| US20090062788A1 (en) * | 2007-08-31 | 2009-03-05 | Long Gary L | Electrical ablation surgical instruments |
| US20090076500A1 (en) * | 2007-09-14 | 2009-03-19 | Lazure Technologies, Llc | Multi-tine probe and treatment by activation of opposing tines |
| US20090138009A1 (en) * | 2007-11-05 | 2009-05-28 | Viswanathan Raju R | Magnetically guided energy delivery apparatus |
| US20110130708A1 (en) * | 2009-05-13 | 2011-06-02 | Minnow Medical, Inc. | Directional Delivery of Energy and Bioactives |
| US20120095459A1 (en) * | 2010-10-13 | 2012-04-19 | Peter Callas | System and Method for Electrically Ablating Tissue of a Patient |
Cited By (109)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10820941B2 (en) | 2006-06-28 | 2020-11-03 | Kardium Inc. | Apparatus and method for intra-cardiac mapping and ablation |
| US11389231B2 (en) | 2006-06-28 | 2022-07-19 | Kardium Inc. | Apparatus and method for intra-cardiac mapping and ablation |
| US11389232B2 (en) | 2006-06-28 | 2022-07-19 | Kardium Inc. | Apparatus and method for intra-cardiac mapping and ablation |
| US11399890B2 (en) | 2006-06-28 | 2022-08-02 | Kardium Inc. | Apparatus and method for intra-cardiac mapping and ablation |
| US10828094B2 (en) | 2006-06-28 | 2020-11-10 | Kardium Inc. | Apparatus and method for intra-cardiac mapping and ablation |
| US10828093B2 (en) | 2006-06-28 | 2020-11-10 | Kardium Inc. | Apparatus and method for intra-cardiac mapping and ablation |
| US10828098B2 (en) | 2007-11-16 | 2020-11-10 | Kardium Inc. | Medical device for use in bodily lumens, for example an atrium |
| US11076913B2 (en) | 2007-11-16 | 2021-08-03 | Kardium Inc. | Medical device for use in bodily lumens, for example an atrium |
| US10828097B2 (en) | 2007-11-16 | 2020-11-10 | Kardium Inc. | Medical device for use in bodily lumens, for example an atrium |
| US10499986B2 (en) | 2007-11-16 | 2019-12-10 | Kardium Inc. | Medical device for use in bodily lumens, for example an atrium |
| US10828095B2 (en) | 2007-11-16 | 2020-11-10 | Kardium Inc. | Medical device for use in bodily lumens, for example an atrium |
| US10828096B2 (en) | 2007-11-16 | 2020-11-10 | Kardium Inc. | Medical device for use in bodily lumens, for example an atrium |
| US11304751B2 (en) | 2007-11-16 | 2022-04-19 | Kardium Inc. | Medical device for use in bodily lumens, for example an atrium |
| US11331141B2 (en) | 2007-11-16 | 2022-05-17 | Kardium Inc. | Medical device for use in bodily lumens, for example an atrium |
| US11432874B2 (en) | 2007-11-16 | 2022-09-06 | Kardium Inc. | Medical device for use in bodily lumens, for example an atrium |
| US11413091B2 (en) | 2007-11-16 | 2022-08-16 | Kardium Inc. | Medical device for use in bodily lumens, for example an atrium |
| US11801091B2 (en) | 2007-11-16 | 2023-10-31 | Kardium Inc. | Medical device for use in bodily lumens, for example an atrium |
| US11633231B2 (en) | 2007-11-16 | 2023-04-25 | Kardium Inc. | Medical device for use in bodily lumens, for example an atrium |
| US11751940B2 (en) | 2007-11-16 | 2023-09-12 | Kardium Inc. | Medical device for use in bodily lumens, for example an atrium |
| US11690684B2 (en) | 2012-05-21 | 2023-07-04 | Kardium Inc. | Systems and methods for selecting, activating, or selecting and activating transducers |
| US10568576B2 (en) | 2012-05-21 | 2020-02-25 | Kardium Inc. | Systems and methods for activating transducers |
| US11633238B2 (en) | 2012-05-21 | 2023-04-25 | Kardium Inc. | Systems and methods for selecting, activating, or selecting and activating transducers |
| US10918446B2 (en) | 2012-05-21 | 2021-02-16 | Kardium Inc. | Systems and methods for selecting, activating, or selecting and activating transducers |
| US12376796B2 (en) | 2012-05-21 | 2025-08-05 | Kardium Inc. | Systems and methods for activating transducers |
| US11805974B2 (en) | 2012-05-21 | 2023-11-07 | Kardium Inc. | Systems and methods for selecting, activating, or selecting and activating transducers |
| US11589821B2 (en) | 2012-05-21 | 2023-02-28 | Kardium Inc. | Systems and methods for activating transducers |
| US11672485B2 (en) | 2012-05-21 | 2023-06-13 | Kardium Inc. | Systems and methods for activating transducers |
| US12376795B2 (en) | 2012-05-21 | 2025-08-05 | Kardium Inc. | Systems and methods for activating transducers |
| US11154248B2 (en) | 2012-05-21 | 2021-10-26 | Kardium Inc. | Systems and methods for activating transducers |
| US12324636B2 (en) | 2012-05-21 | 2025-06-10 | Kardium Inc. | Systems and methods for selecting, activating, or selecting and activating transducers |
| US10827977B2 (en) | 2012-05-21 | 2020-11-10 | Kardium Inc. | Systems and methods for activating transducers |
| US12226172B2 (en) | 2012-05-21 | 2025-02-18 | Kardium Inc. | Systems and methods for selecting, activating, or selecting and activating transducers |
| US10470826B2 (en) | 2012-05-21 | 2019-11-12 | Kardium Inc. | Systems and methods for selecting, activating, or selecting and activating transducers |
| US11426573B2 (en) | 2012-08-09 | 2022-08-30 | University Of Iowa Research Foundation | Catheters, catheter systems, and methods for puncturing through a tissue structure and ablating a tissue region |
| US10517672B2 (en) | 2014-01-06 | 2019-12-31 | Farapulse, Inc. | Apparatus and methods for renal denervation ablation |
| US11589919B2 (en) | 2014-01-06 | 2023-02-28 | Boston Scientific Scimed, Inc. | Apparatus and methods for renal denervation ablation |
| US12390272B2 (en) | 2014-05-07 | 2025-08-19 | Boston Scientific Scimed, Inc. | Methods and apparatus for selective tissue ablation |
| US11259869B2 (en) | 2014-05-07 | 2022-03-01 | Farapulse, Inc. | Methods and apparatus for selective tissue ablation |
| US12408979B2 (en) | 2014-05-07 | 2025-09-09 | Boston Scientific Scimed, Inc. | Methods and apparatus for selective tissue ablation |
| US12137968B2 (en) | 2014-05-16 | 2024-11-12 | Boston Scientific Scimed, Inc. | Methods and apparatus for multi-catheter tissue ablation |
| US10624693B2 (en) | 2014-06-12 | 2020-04-21 | Farapulse, Inc. | Method and apparatus for rapid and selective tissue ablation with cooling |
| US11622803B2 (en) | 2014-06-12 | 2023-04-11 | Boston Scientific Scimed, Inc. | Method and apparatus for rapid and selective tissue ablation with cooling |
| US10433906B2 (en) | 2014-06-12 | 2019-10-08 | Farapulse, Inc. | Method and apparatus for rapid and selective transurethral tissue ablation |
| US11241282B2 (en) | 2014-06-12 | 2022-02-08 | Boston Scientific Scimed, Inc. | Method and apparatus for rapid and selective transurethral tissue ablation |
| US12161397B2 (en) | 2014-06-12 | 2024-12-10 | Boston Scientific Scimed, Inc. | Method and apparatus for rapid and selective transurethral tissue ablation |
| US10835314B2 (en) | 2014-10-14 | 2020-11-17 | Farapulse, Inc. | Method and apparatus for rapid and safe pulmonary vein cardiac ablation |
| US12295648B2 (en) | 2014-10-14 | 2025-05-13 | Boston Scientific Scimed, Inc. | Method and apparatus for rapid and safe pulmonary vein cardiac ablation |
| US12133745B2 (en) | 2014-11-17 | 2024-11-05 | Kardium Inc. | Systems and methods for selecting, activating, or selecting and activating transducers |
| US10758191B2 (en) | 2014-11-17 | 2020-09-01 | Kardium Inc. | Systems and methods for selecting, activating, or selecting and activating transducers |
| US11026637B2 (en) | 2014-11-17 | 2021-06-08 | Kardium Inc. | Systems and methods for selecting, activating, or selecting and activating transducers |
| US11026638B2 (en) | 2014-11-17 | 2021-06-08 | Kardium Inc. | Systems and methods for selecting, activating, or selecting and activating transducers |
| US10368936B2 (en) | 2014-11-17 | 2019-08-06 | Kardium Inc. | Systems and methods for selecting, activating, or selecting and activating transducers |
| US10722184B2 (en) | 2014-11-17 | 2020-07-28 | Kardium Inc. | Systems and methods for selecting, activating, or selecting and activating transducers |
| US12383208B2 (en) | 2014-11-17 | 2025-08-12 | Kardium Inc. | Systems and methods for selecting, activating, or selecting and activating transducers |
| US10751006B2 (en) | 2014-11-17 | 2020-08-25 | Kardium Inc. | Systems and methods for selecting, activating, or selecting and activating transducers |
| US12207866B2 (en) | 2015-08-06 | 2025-01-28 | Medtronic, Inc. | Cardiac pulsed field ablation |
| US12201353B2 (en) | 2015-08-06 | 2025-01-21 | Medtronic, Inc. | Cardiac pulsed field ablation |
| US12150700B2 (en) | 2015-08-06 | 2024-11-26 | Medtronic, Inc. | Cardiac pulsed field ablation |
| US12150701B2 (en) | 2015-08-06 | 2024-11-26 | Medtronic, Inc. | Cardiac pulsed field ablation |
| US10433908B2 (en) | 2016-01-05 | 2019-10-08 | Farapulse, Inc. | Systems, devices, and methods for delivery of pulsed electric field ablative energy to endocardial tissue |
| US10660702B2 (en) | 2016-01-05 | 2020-05-26 | Farapulse, Inc. | Systems, devices, and methods for focal ablation |
| US10512779B2 (en) | 2016-01-05 | 2019-12-24 | Farapulse, Inc. | Systems, apparatuses and methods for delivery of ablative energy to tissue |
| US11589921B2 (en) | 2016-01-05 | 2023-02-28 | Boston Scientific Scimed, Inc. | Systems, apparatuses and methods for delivery of ablative energy to tissue |
| US10172673B2 (en) | 2016-01-05 | 2019-01-08 | Farapulse, Inc. | Systems devices, and methods for delivery of pulsed electric field ablative energy to endocardial tissue |
| US10709891B2 (en) | 2016-01-05 | 2020-07-14 | Farapulse, Inc. | Systems, apparatuses and methods for delivery of ablative energy to tissue |
| US10842561B2 (en) | 2016-01-05 | 2020-11-24 | Farapulse, Inc. | Systems, devices, and methods for delivery of pulsed electric field ablative energy to endocardial tissue |
| US10322286B2 (en) | 2016-01-05 | 2019-06-18 | Farapulse, Inc. | Systems, apparatuses and methods for delivery of ablative energy to tissue |
| US11020179B2 (en) | 2016-01-05 | 2021-06-01 | Farapulse, Inc. | Systems, devices, and methods for focal ablation |
| US12144541B2 (en) | 2016-01-05 | 2024-11-19 | Boston Scientific Scimed, Inc. | Systems, apparatuses and methods for delivery of ablative energy to tissue |
| US10507302B2 (en) | 2016-06-16 | 2019-12-17 | Farapulse, Inc. | Systems, apparatuses, and methods for guide wire delivery |
| US12246143B2 (en) | 2016-06-16 | 2025-03-11 | Boston Scientific Scimed, Inc. | Systems, apparatuses, and methods for guide wire delivery |
| US12403305B2 (en) | 2016-06-27 | 2025-09-02 | Galvanize Therapeutics, Inc. | Immunostimulation in the treatment of viral infection |
| US12349967B2 (en) | 2016-06-27 | 2025-07-08 | Galvanize Therapeutics, Inc. | Methods, apparatuses, and systems for the treatment of pulmonary disorders |
| US10702337B2 (en) | 2016-06-27 | 2020-07-07 | Galary, Inc. | Methods, apparatuses, and systems for the treatment of pulmonary disorders |
| US11369433B2 (en) | 2016-06-27 | 2022-06-28 | Galvanize Therapeutics, Inc. | Methods, apparatuses, and systems for the treatment of pulmonary disorders |
| US10939958B2 (en) | 2016-06-27 | 2021-03-09 | Galary, Inc. | Methods, apparatuses, and systems for the treatment of pulmonary disorders |
| US11357978B2 (en) | 2017-04-27 | 2022-06-14 | Boston Scientific Scimed, Inc. | Systems, devices, and methods for signal generation |
| US12121720B2 (en) | 2017-04-27 | 2024-10-22 | Boston Scientific Scimed, Inc. | Systems, devices, and methods for signal generation |
| US9987081B1 (en) | 2017-04-27 | 2018-06-05 | Iowa Approach, Inc. | Systems, devices, and methods for signal generation |
| US10016232B1 (en) | 2017-04-27 | 2018-07-10 | Iowa Approach, Inc. | Systems, devices, and methods for signal generation |
| US10617867B2 (en) | 2017-04-28 | 2020-04-14 | Farapulse, Inc. | Systems, devices, and methods for delivery of pulsed electric field ablative energy to esophageal tissue |
| US11833350B2 (en) | 2017-04-28 | 2023-12-05 | Boston Scientific Scimed, Inc. | Systems, devices, and methods for delivery of pulsed electric field ablative energy to esophageal tissue |
| US10617467B2 (en) | 2017-07-06 | 2020-04-14 | Farapulse, Inc. | Systems, devices, and methods for focal ablation |
| US10130423B1 (en) | 2017-07-06 | 2018-11-20 | Farapulse, Inc. | Systems, devices, and methods for focal ablation |
| US12150698B2 (en) | 2017-09-12 | 2024-11-26 | Boston Scientific Scimed, Inc. | Systems, apparatuses, and methods for ventricular focal ablation |
| US10893905B2 (en) | 2017-09-12 | 2021-01-19 | Farapulse, Inc. | Systems, apparatuses, and methods for ventricular focal ablation |
| US12295637B2 (en) | 2018-02-08 | 2025-05-13 | Boston Scientific Scimed, Inc. | Method and apparatus for controlled delivery of pulsed electric field ablative energy to tissue |
| US12042208B2 (en) | 2018-05-03 | 2024-07-23 | Boston Scientific Scimed, Inc. | Systems, devices, and methods for ablation using surgical clamps |
| US10512505B2 (en) | 2018-05-07 | 2019-12-24 | Farapulse, Inc. | Systems, apparatuses and methods for delivery of ablative energy to tissue |
| US11033236B2 (en) | 2018-05-07 | 2021-06-15 | Farapulse, Inc. | Systems, apparatuses, and methods for filtering high voltage noise induced by pulsed electric field ablation |
| US11020180B2 (en) | 2018-05-07 | 2021-06-01 | Farapulse, Inc. | Epicardial ablation catheter |
| US12257080B2 (en) | 2018-05-07 | 2025-03-25 | Boston Scientific Scimed, Inc. | Systems, apparatuses, and methods for filtering high voltage noise induced by pulsed electric field ablation |
| US10709502B2 (en) | 2018-05-07 | 2020-07-14 | Farapulse, Inc. | Systems, apparatuses and methods for delivery of ablative energy to tissue |
| US12274491B2 (en) | 2018-05-07 | 2025-04-15 | Boston Scientific Scimed, Inc. | Epicardial ablation catheter |
| US10687892B2 (en) | 2018-09-20 | 2020-06-23 | Farapulse, Inc. | Systems, apparatuses, and methods for delivery of pulsed electric field ablative energy to endocardial tissue |
| US12318130B2 (en) | 2018-09-20 | 2025-06-03 | Boston Scientific Scimed, Inc. | Systems, apparatuses, and methods for delivery of pulsed electric field ablative energy to endocardial tissue |
| US10688305B1 (en) | 2019-09-17 | 2020-06-23 | Farapulse, Inc. | Systems, apparatuses, and methods for detecting ectopic electrocardiogram signals during pulsed electric field ablation |
| US10625080B1 (en) | 2019-09-17 | 2020-04-21 | Farapulse, Inc. | Systems, apparatuses, and methods for detecting ectopic electrocardiogram signals during pulsed electric field ablation |
| US11738200B2 (en) | 2019-09-17 | 2023-08-29 | Boston Scientific Scimed, Inc. | Systems, apparatuses, and methods for detecting ectopic electrocardiogram signals during pulsed electric field ablation |
| US11497541B2 (en) | 2019-11-20 | 2022-11-15 | Boston Scientific Scimed, Inc. | Systems, apparatuses, and methods for protecting electronic components from high power noise induced by high voltage pulses |
| US11065047B2 (en) | 2019-11-20 | 2021-07-20 | Farapulse, Inc. | Systems, apparatuses, and methods for protecting electronic components from high power noise induced by high voltage pulses |
| US11684408B2 (en) | 2019-11-20 | 2023-06-27 | Boston Scientific Scimed, Inc. | Systems, apparatuses, and methods for protecting electronic components from high power noise induced by high voltage pulses |
| US11931090B2 (en) | 2019-11-20 | 2024-03-19 | Boston Scientific Scimed, Inc. | Systems, apparatuses, and methods for protecting electronic components from high power noise induced by high voltage pulses |
| US12349953B2 (en) | 2019-11-20 | 2025-07-08 | Boston Scientific Scimed, Inc. | Systems, apparatuses, and methods for protecting electronic components from high power noise induced by high voltage pulses |
| US10842572B1 (en) | 2019-11-25 | 2020-11-24 | Farapulse, Inc. | Methods, systems, and apparatuses for tracking ablation devices and generating lesion lines |
| US12268437B2 (en) | 2020-07-24 | 2025-04-08 | Boston Scientific Scimed, Inc. | Electric field application for single shot cardiac ablation by irreversible electroporation |
| US12310652B2 (en) | 2020-07-24 | 2025-05-27 | Boston Scientific Scimed, Inc. | Hybrid electroporation ablation catheter |
| US12349964B2 (en) | 2020-09-30 | 2025-07-08 | Boston Scientific Scimed, Inc. | Pretreatment waveform for irreversible electroporation |
| US12343071B2 (en) | 2021-01-27 | 2025-07-01 | Boston Scientific Scimed, Inc | Voltage controlled pulse sequences for irreversible electroporation ablations |
Also Published As
| Publication number | Publication date |
|---|---|
| US20220000547A1 (en) | 2022-01-06 |
| US20170065340A1 (en) | 2017-03-09 |
| WO2015175944A1 (en) | 2015-11-19 |
| US12137968B2 (en) | 2024-11-12 |
| US20250064511A1 (en) | 2025-02-27 |
| EP3142584A1 (en) | 2017-03-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US12137968B2 (en) | Methods and apparatus for multi-catheter tissue ablation | |
| US12295648B2 (en) | Method and apparatus for rapid and safe pulmonary vein cardiac ablation | |
| US12408979B2 (en) | Methods and apparatus for selective tissue ablation | |
| JP7483628B2 (en) | Systems, devices and methods for ablation using surgical clamps - Patents.com | |
| CN111227926B (en) | Pulser for irreversible electroporation | |
| EP3831442A1 (en) | Using reversible electroporation on cardiac tissue | |
| JP2024081699A (en) | Systems, devices and methods for localized ablation - Patents.com | |
| JP2021087779A (en) | Pulse generator for irreversible electroporation | |
| JP2022013664A (en) | Temperature control for ire | |
| JP2022162997A (en) | Pulse generator for irreversible electroporation with switchable pulse application |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AS | Assignment |
Owner name: IOWA APPROACH, INC., CALIFORNIA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:GLL, LLC;LONG, GARY L.;REEL/FRAME:044152/0930 Effective date: 20150909 |
|
| AS | Assignment |
Owner name: FARAPULSE, INC., CALIFORNIA Free format text: CHANGE OF NAME;ASSIGNOR:IOWA APPROACH, INC.;REEL/FRAME:047763/0221 Effective date: 20180531 |
|
| STPP | Information on status: patent application and granting procedure in general |
Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION |
|
| STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
| STPP | Information on status: patent application and granting procedure in general |
Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER |
|
| STPP | Information on status: patent application and granting procedure in general |
Free format text: FINAL REJECTION MAILED |
|
| STPP | Information on status: patent application and granting procedure in general |
Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION |
|
| AS | Assignment |
Owner name: BOSTON SCIENTIFIC SCIMED, INC., MASSACHUSETTS Free format text: SECURITY INTEREST;ASSIGNOR:FARAPULSE, INC.;REEL/FRAME:053596/0364 Effective date: 20200821 |
|
| STCV | Information on status: appeal procedure |
Free format text: NOTICE OF APPEAL FILED |
|
| STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |
|
| AS | Assignment |
Owner name: BOSTON SCIENTIFIC SCIMED, INC., MINNESOTA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:FARAPULSE, INC.;REEL/FRAME:060802/0286 Effective date: 20210806 |